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QUORUM SENSING INHIBITORY ACTIVITIES OF VARIOUS FOLK MEDICINAL
PLANTS AND THE ELUCIDATION OF THE THYME-TETRACYCLINE EFFECT
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MARIA M. NAGY
Under the Direction of Dr. Sidney A. Crow

ABSTRACT

Pseudomonas aeruginosa is an opportunistic, nosocomial pathogen for which antibiotic
resistance and biofilm development is common. Quorum sensing communication is known to be
a major controlling factor in virulence gene expression, biofilm development, antibiotic
resistance factors, and specifically MexAB-OprM multi-drug efflux pump expression in
P.aeruginosa. MexAB-OprM efflux pumps contribute to antibiotic resistance of tetracycline and
other antibiotics in pseudomonads and other organisms. P.aeruginosa infections are problematic
in cystic fibrosis and burn patients; it is also the number one causative agent of respiratory
infections for intensive care unit patients. Present day antibiotics are losing the battle against
these infections. In theory, quorum sensing inhibitors (QSI) reduce pathogencity of the organism;
making it less virulent, thus allowing either the host immune system to clear the infection or use
of a QSI in combination with an antibiotic to clear more persistent pathogens. For these reasons

two alternative modes of treatment were explored in this study: quorum sensing inhibition by
folk-medicinal plant extracts and an example of combination drug therapy, the ―thymetetracycline effect‖.
Fifty folk-medicinal plant extracts were screened for potential anti-quorum sensing
activity using two quorum sensing inhibition (QSI) reporter strains, Pseudomonas aeruginosa
QSIS2 and Chromobacterium violaceum 12725. These were used to test specifically for C4-C6
and C12 HSL quorum sensing inhibition. Of the fifty plants tested, thirty plant families were
represented. Eleven plant extracts (basil, chaparral, clove, cranberry, oregano, pomegranate,
rosemary, sage, sassafras, thyme and witch hazel) showed C4 HSL quorum sensing inhibition as
determined by both assays. Interestingly, five of the plants were from the Lamiaceae family.
Thymus vulgaris (thyme), also from the Lamiaceae family, was chosen for further assessment.
Previous research has shown that thyme extract can synergistically augment tetracycline
activity against tetracycline-resistant Pseudomonas aeruginosa, creating the ―thyme-tetracycline
effect.‖ Disc diffusion assay, thin layer chromatography (TLC), and TLC bioassay techniques
were used to show that thymol is the active component in the thyme extract that augments
tetracycline activity against resistant Pseudomonas. This study also showed that thymol is a
potent C4 HSL quorum sensing inhibitor. The collective data suggests a potential mode of action
for the thyme-tetracycline effect: thymol appears to prevent MexAB-OprM efflux pump gene
expression. By blocking MexAB-OprM expression, tetracycline antibiotic accumulation can
occur within the cell, thus allowing cellular damage.
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INTRODUCTION
Infectious Disease
Infectious diseases are defined by the World Health Organization (WHO) as diseases
caused by microbes; these microbes may include bacteria, fungi, protozoa, and viruses (WHO,
2010). These organisms may be found in either the environment or participate in normal
commensal flora for humans, plants, or animals. When in their natural environment, these
microbes are typically kept in balance by the surrounding flora. Thus, many of these organisms
can be beneficial to their environment by providing nutrient turnover; but when certain bacteria
are introduced into a foreign niche within the human body, they may cause disease. Diseases
caused by bacterial infections can range from severe to mild and may include wound infections,
pneumonia, septicemia, endocarditis, colds, and eye and ear infections (Todar, 2008).
Prior to the discovery of penicillin antibiotics, doctors were unable to treat even relatively
simple bacterial infections such as otitis media (inner ear infection) and streptococcal infection
of the throat (Office of Technical Assessment [OTA], 1995). Doctors were instructed to keep
the infected patient clean and comfortable until the immune system could clear the infection;
more serious infections, however, were incurable (OTA, 1995). The treatment of bacterial
infections was revolutionized in 1929, when Alexander Fleming discovered penicillin. For
several years, antibiotics were thought to be the ―end-all‖ curative agent for many bacterial
infections and were considered to be the wonder drug of the era. Penicillin was used to treat
infections caused by Staphylococci, Streptococci and other Gram-positive organisms (OTA,
1995). On August 14, 1944, Schenley Laboratories unveiled an advertisement campaign in Life
magazine (Figure 1) that suggested the revolutionary usefulness of penicillin on the battle field
(Levy, 2002).
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Figure 1: Life magazine--Advertisement for penicillin (1944).
ncmuseumofhistory.org/.../topic/16/

However, by 1945 penicillin-resistant strains of Staphylococcus aureus were being
isolated in hospitals. Methicillin, a semi-synthetic version of penicillin, was introduced in 1959
in hopes of combating these resistant strains. Only one year later, the first isolates of methicillinresistant strains of S. aureus (MRSA) were being found in hospitals in the United States.
Vancomycin was introduced in 1956 to treat MRSA (OTA, 1995).

The first case of

vancomycin resistance was seen in Japan in 1996 (CDC, 2002).
In 2001, WHO officially deemed antibiotic resistance the number three public health
concern of the 21st century (Levy, 2002). In April of 2010, the ―10 x‘20‖ initiative was launched
by the Infectious Disease Society of America (IDSA) to assist in the development of 10 new
antibiotic drugs by the end of 2020. The focus of this drug development initiative is to target
specific infectious agents deemed ―ESKAPE‖ pathogens. These organisms include:
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumamnii, Pseudomonas aeruginosa and Enterobacter species, and represent the most
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prominent causes of hospital-acquired infections today. ―ESKAPE‖ also refers to the ability of
these organisms to ―escape‖ present-day antimicrobial treatments (IDSA, 2010). Clearly,
exploration of new and alternative drug treatments for infectious diseases is vital.
One particularly troubling organism is Pseudomonas aeruginosa; it is a nosocomial, or
hospital-acquired, opportunistic pathogen. It is the number one infectious agent causing
respiratory infections in people with extended hospital stays (Driscoll et al., 2007).

Pseudomonas aeruginosa
Pseudomonas aeruginosa (Figure 2) is a Gram-negative rod that is propelled by a single
flagellum (Todar, 2008). Pseudomonas is a genus within the medically-relevant class of
Gammaproteobacteria, and belongs to the family Pseudomonadaceae. There are eight genera in
the family Pseudomonadaceae and twelve species in the genus Pseudomonas. P. aeruginosa,
native to both soil and water, is also a well-known plant pathogen (Todar, 2008). As a human
pathogen, opportunistic infections by this organism can occur when the host immune system is
previously weakened due to a prior ailment-such as AIDS, cancer, cystic fibrosis,
transplantation, or substantial burns (Driscoll et al., 2007). In these scenarios, pseudomonad‘s
have the ability to infect any tissue where the defenses of the host have been compromised
(Todar, 2008). While P. aeruginosa infections are most commonly associated with pneumonia
in cystic fibrosis patients and wound infections of burn patients, it is also the causative agent of
several other illnesses including urinary tract infections, endocarditis, bactermia (Todar, 2008),
ulcerative keratitis (in contact lens wearers) and otitis externa (in diabetics) (Driscoll et al.,
2007). P. aeruginosa is also estimated to be the causative agent in 11%-13% of all nosocomial
infections, in 13%-22% of infections in intensive care units (ICUs), and in 16% of all surgical
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site infections (Driscoll et al., 2007). Furthermore, it is the second-most common cause of
health-associated and ventilator-associated pneumonia (Driscoll et al., 2007).

Figure 2: Scanning electron micrograph of Pseudomonas aeruginosa-(CDC).
(Todar, 2008)

Virulence
When P. aeruginosa infects the host, it expresses a myriad of virulence factors that allow
it to attack the host immune system while evading treatment. An intrinsic defensive feature of
this organism is its outer phospholipid membrane which has limited permeability for most
molecules.
Pseudomonads also secrete a number of compounds that interfere with host defenses
including enzymes, exotoxins, and pyocyanin. Enzymes, such as alkaline protease, elastase, and
other proteases, aid in degrading host proteins Exotoxins, including Exotoxin A, interfere with
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protein synthesis and can even cause cellular death. Pyocyanin is a blue-green pigment which is
bactericidal against competing organisms. In the lungs, pyocyanin can also disrupt ciliary action
and cause inflammation (Driscoll et al., 2007).
Another virulence factor that can be expressed in Pseudomonas is the type III secretion
apparatus. Expression of the genes encoding the various parts of the secretion system is seen
predominantly in acute or invasive infections more than in chronic infections (Driscoll et al.,
2007). This mechanism is a ―contact-dependent‖ system that is triggered by the interaction of P.
aeruginosa with the host cell. The secretion apparatus allows the cell to inject exoenzymes
directly into the host cell. There are four known exoenzymes that are typically expressed by P.
aeruginosa: Exo S, Exo T, Exo U, and Exo Y (Driscoll et al., 2007). These exoenzymes can
damage the host‘s cellular machinery and even cause cell death (Driscoll et al., 2007).
In addition to the impermeability of the cellular membrane and the secretion apparatus,
Pseudomonas also has another mechanism of protection. If a damaging molecule does gain
entry into the cell, then unique pumps quickly expel the compounds from the cell before any
damage can occur. These efflux pumps can remove antibiotics, dyes, detergents, solvents and
other compounds from the cell before they can cause harm (Driscoll et al., 2007). There are two
types of efflux pumps that are seen in bacteria: those which are encoded in the chromosome and
those which are plasmid borne. For example, the MexAB-OmpM efflux pumps found in P.
aeruginosa are intrinsic to the genome. Plasmid-borne antibiotic resistance genes that code for
efflux pumps can be located on specialty plasmids, such as tetracycline-resistant (Tc) plasmids.
These plasmids are typically transferred through conjugation between bacteria and can encode
for multi-drug resistance pumps (Chopra and Roberts, 2001).
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Biofilms
A final mechanism for protection from the host immune system may be incurred through
biofilm formation. It well known that bacteria grow and develop into ―tight-knit‖ communities
on biotic and abiotic surfaces. The innate features of a biofilm can protect bacteria from
antibiotic damage. Biofilms are so efficient in preventing antibiotic damage that concentrations
of antibiotics must be increased by 100-1000--fold to be effective (Costerton et al., 1994).
Biofilms (Figure 3-A) typically consist of microbial communities that secrete and are
encased in a thick exopolysaccharide matrix. There are special features associated with most
biofilms that allow for increased efficiency of these communities. These particular morphological
characteristics include: an attachment surface, mushroom-like clusters of bacterial cells, a thick
polysaccharide matrix encasing the bacterial communities; extensive well-hydrated channels that
allow for directed liquid flow (providing delivery and removal of nutrients and waste products);
and swarmer cells (Figure 3-B). Swarmer cells are cells that easily break off from the mushroom
structure, and are thus able to relocate and re-populate a new location (Costerton et al., 1994).
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A

B

Figure 3: Biofilms. A) Mixed colony biofilm from Bow River Alberta, Canada; B) Diagram of a
biofilm: Notice the following features: mushroom structures, thick polysaccharide matrix,
excessive channels, well hydrated channels, directed flow (allowing for delivery of nutrients and
removal of waste products and swarmer cells. (Costerton et al., 1994)

Medical devices, such as internal catheters, artificial joints, and heart value replacement
units, have become commonplace in medicine. While these advances have extended the lives of
many, they have also ironically brought about subsequent problems. The number of people that
are in extended ―immuno-compromised‖ states has greatly increased. Unfortunately, medical
devices provide the perfect breeding ground for the development of opportunistic bacterial and
biofilm infections, and for the proliferation of resistant bacteria (Reid, 1999).
As of 1999, catheter and urinary stent usage occurred in over 100 million patients per
year (Reid, 1999). Sixty percent of all hospital-acquired microbial infections are caused by
biofilms (Lewis, 2001). Without the use of prophylactic antibiotic treatments, the infection rate
for urethral stents is 28% and is nearly 100% with catheter usage. For this reason, prophylactic
antibiotic treatments are administered to patients to reduce infection rates (Reid, 1999).
There are many features of a catheter that promote bacterial growth. These features
include liquid flow, nutrient access, attachment surface, and the occasional planktonic organism, all
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of which are readily associated with biofilm development. Because of this, biofilm infections are
prominent in catheter-type environments. If a biofilm does develop, then it requires an antibiotic
dosage of a 100-1000 times greater concentration of antibiotics than with non-biofilm bacterial
infections. The excessive use of these antibiotic treatments increases the development of resistant
bacteria, thus reducing the overall effectiveness of available antibiotics (Costerton, 1999).
Many characteristics of biofilms contribute to the difficulty in treating these types of
infections with normal antibiotic doses. First, the exopolysaccharide matrix produces a physical
barrier, which reduces the amount of antibiotic that can enter into this microbial community.
Second, even if antibiotic treatments infiltrate the exopolysaccharide matrix, the antibiotic may
still have difficultly accessing the internal cells of the mushroom-like structures. Third, during the
formation of a biofilm, specialized virulence gene expression can occur. These virulence factors
include the expression of antibiotic denaturing enzymes, efflux pump, and increased plasmid
exchange.

The development and expression of many of these virulence features is typically under

quorum sensing control (Bassler, 1999; Camara et al., 2002; Costerton, 1999; Lewis, 2001).

Quorum Sensing

Quorum sensing (QS) is a population-dependent expression of genes that influences
biofilm development, efflux pump expression, toxin production, and many other virulence factors.
Quorum sensing occurs through chemical signaling and has been observed in bacteria, fungi, and
even plants. Individual cells in an environment constantly express and expel low levels of quorum
sensing molecules. It is only when the cell population reaches a certain concentration that the
threshold gradient is achieved; these signal molecules diffuse back into the cell and bind to a
transcription regulator. This binding triggers the expression of QS-mediated genes, and the entire
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population thus responds in a joint expression or repression of a multitude of genes. It has been
shown that many organisms have variations on this quorum sensing theme (Bassler, 1999; Camara
et al., 2002; Hogan et al., 2004; Otto, 2004). Quorum sensing responses may result from intraspecies or interspecies communication. In this way, bacteria within a given area can attack the host
as unified army (Bassler, 1999).
While the basics are similar, there are some differences with Gram-positive quorum
sensing. First Gram-positive organisms use small peptide units called pheromones as their QS
molecules. They also use transmembrane proteins and they utilize a two- component signal
transduction system in order to trigger QS-mediated gene expression. For example, in
Staphylococcus aureus QS communication is encoded on the agrACDB operon. First the Agr D
gene product produces a nonreactive oligopeptide, which later becomes cleaved and a small peptide
unit is exported from the cell by the AgrB ATP binding cassette transmembrane protein.

When the

concentration of these newly expelled pheromone units reach quorum levels, they eventually bind to
a second transmembrane protein, AgrC. Next, the AgrC protein; can autophophorylate the
transcription regulator, AgrA. Lastly, the phosphorylated AgrA will bind to the P3 promoter sites
of the agrACDB operon triggering the expression of RNA III. RNA III will up regulate or down
regulate the expression of many quorum sensing mediated genes such as surface proteinsfibronectin-binding protein, coagulase, toxin expression-enteroxin (TSS), and toxic shock syndrome
toxin (TSST-1) (Camara et al., 2002; Otto, 2004).
One of the QS motifs found in Gram-negative bacteria is the Lux I/R system.

An

autoinducer synthase, Lux I, is responsible for manufacturing QS molecules called acyl homoserine
lactone (AHL) derivatives. Acyl homoserine lactones are lactone rings with a carbonyl tail (C4-C16)
with varying functional lengths. QS molecules are excreted into the extra-cellular environment.
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When the organisms grow to sufficient density, the concentration of the AHL reaches a critical
value; these compounds diffuse back down their concentration gradient and into the cell, binding to
an autoinducer regulator compound, Lux R. This triggers the expression of quorum sensing
controlled genes. One main difference between the Lux R/I system and other QS systems is that
transmembrane proteins are not used predominantly because acyl homoserine lactone units tend to
be small carbon (C4-C6) units (Bassler, 1999).
In Pseudomonas, the quorum sensing mechanism consists of two main cascading
regulatory systems Las I/R and Rhl I/R (Figure 4) and varying size acyl-homoserine lactone units
(Bassler, 1999). There is a low level constitutive expression of the Las I gene product, N-(3oxododecanoyl) homoserine lactone (3-oxo-C12-HSL) (Figure 5). When the 3-oxo-C12-HSL signal
molecule binds to the Las R regulator protein, two functions are carried out. First, it triggers
modulation of QS-regulated genes including genes associated with exoenzymes- elastase, alkaline
and acid proteases, exotoxin A, secretion apparatus (Xcp) and biofilm development. Second, it also
triggers the cascading regulatory expression of Rhl I/R genes. Rhl I/R gene products control the
expression of a number of secondary genes including regions that code for: elastase, lectins,
hydrogen cyanide, rhamnolipids and siderophores. Expression of these genes occurs when the gene
product of Rhl I, N-(butanoyl)-L- homoserine lactone (C4-HSL) (Figure 6) is excreted into the
environment; also reaching sufficient levels, and diffusing back into the cell thus binding to the Rhl
R regulatory protein (Camara et al., 2002).
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Figure 4: Quorum Sensing cascading system in Pseudomonas aeruginosa.
(Camara et al., 2002)
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Figure 6: N-(butanoyl)-L-homoserine lactone. (C4-HSL).
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Prevention and Treatment
Complete eradication of P. aeruginosa in hospitals is likely unattainable, since
Pseudomonas species can be found growing in every conceivable reservoir in the hospital
environment. Reduction is the first line of defense when it comes to infections in hospitals.
Reducing nosocomial infection rates can be achieved thru methods such as: proper disinfecting,
aseptic techniques and monitoring of patient respirators, ventilators, and other equipment
(Driscoll et al., 2007). However if an infection does occur, antibiotic treatment is needed.
P. aeruginosa infections are typically treated with aminoglycosides antibiotics such as:
gentamicin, tobramycin, monobactams, and some flouroquinolones antibiotics.

Antibiotics
In general there are five major groups of antibiotics used to treat most bacterial
infections: β-lactams, sulfonamides, streptomycin, chloramphenicol, and tetracyclines. There are
three major sources from which these well known antibiotics are derived. These are the molds
Penicillium and Cephalosporium, the Actinomycetes, such as Streptomyces spp., and the Grampositive Bacillus spp. Penicillium and Cephalosporium molds produce the β-lactam antibiotics
such as: penicillin, cephalosporin; semi-synthetic versions such as amoxicillin and ampicillin are
also available. These drugs interfere with cell wall development.
Actinomycetes, such as Streptomyces, are the source for: the aminoglycosides,
macrolides, tetracyclines and chloramphenicol. These antibiotics interfere with ribosome or
protein synthesis in the target bacteria. Bacillus spp. produces polypeptide antibiotics such as
polymixins, and bacitracin. Polymixin disrupts phospholipid membrane function, while
bacitracin affects cell wall growth (Todar, 2008).
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Antibiotic Resistance
Antibiotic resistance is a major problem encountered by physicians treating bacterial
infections. There are some antibiotics to which pseudomonads are naturally resistant. These
include: macrolides, β-lactams, tetracyclines and some fluoroquinolones (Driscoll et al., 2007).
Pseudomonads, as well as other Gram-negative organisms‘ posse several mechanisms which
promote antimicrobial resistance to common antibiotics. First, they have an outer phospholipid
membrane that creates a selective barrier, which limits uptake into the cell. Next, many bacteria
can express a number of proteins that can either degrade or expel the antibiotic from the cell.
For instance, efflux pumps can quickly expel a number of compounds from the cell before they
can cause injury to the cell‘s machinery. Third, many bacteria quickly develop into biofilm
communities. These biofilms are quite resistant to antibiotic treatment. Lastly, resistance by
bacteria is also easily gained by conjugation and plasmid transfer of antibiotic resistance genes
between organisms. It is through these mechanisms that many bacteria can circumvent
antibiotic treatments. For instance, Pseudomonas aeruginosa is naturally resistant to tetracycline
antibiotics.

Tetracycline
The tetracycline family of antibiotics was first discovered in the 1940‘s and originally
isolated from Streptomyces. They are broad-spectrum antibiotics that are effective against both
Gram-positive and Gram-negative bacteria. They are also used to treat chlamydia, rickettsia,
mycoplasms and some protozoa. Tetracycline (Figure 7-A) disables protein synthesis in a cell
by binding to the ribosomal acceptor (A) site of the aminoacyl t-RNA (Chopra and Roberts,
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2001). The family of tetracycline antibiotics includes: chlorotetracycline, oxytetracycline,
tetracycline, demethylchlorotetracycline, and minocycline.
The tetracycline scaffolding (Figure 7-B) has four 6-carbon rings designated as A, B, C
and D, with varying functional groups. 6-deoxy-6-demethyltetracycline (Figure 7-C) is the
simplest known tetracycline to show antimicrobial activity. From this scaffolding, functional
side groups may be added and removed to augment activity and reduce toxicity (Chopra and
Roberts, 2001).
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Figure 7: Tetracycline structures. A) Tetracycline B) Tetracycline Scaffolding, R indicates
locations where functional groups can be added and removed to augment activity, C) 6-deoxy-6demethyltetracycline, the minimum tetracycline structure which shows antibiotic activity,
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In Gram-negative organisms, tetracyclines are strong chelating agents; prior to entering
the cell they bind to positively charged cations such as magnesium (Mg+). This tetracycline
complex gains entry into the cell via OmpC porin channels and accumulates in the periplasmic
space where it dissociates from the cation. Tetracycline is mildly lipophilic so it can easily
diffuse through the bi-lipid membrane and gain entry into the cytoplasm of the cell. In Grampositive organisms, tetracycline takes advantage of the proton motive force and it is thrust
through the cytoplasmic membrane, where it will bind another magnesium ion. The complex
then settles into the A site of the of the 30S ribosomal subunit. This binding of tetracycline
prevents normal binding of aminoacyl t-RNA to the A site of the ribosome and thus disrupting
normal protein synthesis within the cell (Chopra and Roberts, 2001).

Intrinsic Expression of Efflux Pumps
Bacteria can intrinsically express a number of multidrug resistant (MDR) efflux pumps.
These efflux pumps are made up of three protein subunits, which each function to bridge
different sections of the phospholipid bilayer of the bacterial membrane.

In Gram-negative

organisms; there are two phospholipid bilayers (outer and inner membranes) that are located on
either side of the periplasmic space. The outer membrane factor (OMP) crosses the outer
membrane; the periplasmic membrane fusion protein (MFP) covers the periplasmic space.
Lastly, proteins called the Resistance–Nodulation-Division proteins (RND); transverse the inner
membrane of the cells. Nomenclatures for these complexes are written as: RND-MFP-OMP
types.
P. aeruginosa has four well known tripartate efflux systems. These are the MexABOprM, MexCD-OprJ, MexEF-OprN and MexXY-OprM (Poole, 2001). While MexAB-OprM
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(Figure 8) is heavily involved in tetracycline resistance, it is also involved in the removal of
other substrates including: β-lactams, fluoroquinolones, chloramphenicol, novobiocin,
macrolides, ethidium bromide, crystal violet, sodium dodecanoyl sulfate, toluene, aromatic
hydrocarbons, and homoserine lactones (Poole, 2001).

Figure 8: MexAB-OprM multidrug efflux pump. OM: outer membrane, CM: cytoplasmic or
inner membrane. © 2009 University of Cambridge Department of Pharmacology

Expressions of these complexes are under multi-level control. For, the MexAB-OprM
pump, Mex R is the auto-regulating negative repressor for the MexAB-OprM operon. MexABOprM is also under quorum sensing control.
In Pseudomonas aeruginosa, the MexAB-OprM pump, releases the C12HSL QS
molecule. After quorum levels are reached, this molecule diffuses back into the cell, after which
a second QS signal molecule, C4HSL, is expressed. It is this second signal molecule which
greatly up-regulates the expression of MexAB-OprM and other MDR efflux pumps. Maximum
transcription expression of these pumps is typically achieved during the mid-stationary growth
phase of the cells. Lastly, down-regulation of MexAB-OprM is under the control of Mex T.
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Mex T is the positive regulator protein of a second efflux pump system MexEF-OprM. It is this
protein which represses further transcription of the MexAB-OprM gene transcription (Maseda et
al., 2004).

Plasmid Gene Expression Efflux Pumps
Tetracycline resistance genes can be found on Tetracycline-resistant (Tc) plasmids
(Chopra and Roberts, 2001). There have been up to 29 tetracycline resistance genes (tet) that
have been identified and at least 3 oxytetracycline resistance genes (orp) that have been
characterized in both Gram-positive and Gram-negative organisms. P. aeruginosa is known to
express four ―tet” genes: tet(A), tet(C), tet(E) and tet(G). These genes code for multi-drug
resistant efflux pumps which function to expel the antibiotic from the cell. These ―tet‖ genes
typically code for two proteins: a repressor and the efflux pump complex. Expression of these
genes is partially regulated by the absence or presence of the antibiotic. For instance, in the
absence of tetracycline in the cell, a repressor protein prevents the exposure of the ―tet‖ gene
promoter binding site. At the appearance of even nanomolar concentrations of tetracycline in the
cell, the Tetracycline-Mg+ complex binds to the repressor, it to change conformation and release
the binding site. This binding of the Tetracycline-Mg+ complex thus allows for transcription of
the efflux pump genes (Chopra and Roberts, 2001).

Statistical Data about P. aeruginosa Resistance Found in Hospitals
A 2003 study (Driscoll et al., 2007) of P. aeruginosa resistance in ICU units showed that
approximately 22% percent of isolates were resistant to imipenem. There was almost a 30%
resistance to flouroquinolones and a 32% resistance for cephalosporins. Within a 5 year span
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there was a 15% surge (from 1% to 16%) of multi-drug resistance pseudomonad strains that are
resistant to three or more antibiotics (Driscoll et al., 2007). For these reasons, alternate
therapeutic leads are being explored.

Folk-Medicinal Leads
According to the WHO, 70-80% of the world‘s population still relies on folk-medicinal
medicine as part of their main form of medical treatments (WHO, 2008). The pharmaceutical
community has taken this knowledge to heart. Ethnopharmacology as this concept is called is the
theory of looking at folk medicinal treatments and assessing then as potential leads in drug
development. Twenty-five percent of all drugs on the market have at least one compound derived
from a plant source. If fungal and animal sources are included, the number jumps to 40%
(Houghton, 2001). There are several successful drugs that have been derived from plant or fungal
sources. For instance, Taxol isolated from the Pacific yew tree, is one of the most successful
anticancer treatments to date, with over 11 billion in revenue the first few years on the market
(Stephenson, 2004). Ephedrine, a popular bronchodilator, was derived from the folk-medicinal
plant Ma Hung, which demonstrates medicinal properties that were first recorded in China 5,000
years ago (Abourashed et al., 2003). Because of their history of medicinal properties, many folkmedicinal plants have been screened for antibacterial (Cowen, 1999) and anti-quorum sensing
activities (Adonizio et al., 2006; Rasmussen et al., 2005b).
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Quorum Sensing Inhibitors
Studies have found that one method of defense used by many organisms to protect
themselves from invading microbes is the production of compounds called quorum sensing
inhibitors (QSI). Bacteria, fungi and plants have all been shown to produce these compounds,
which interfere with the QS-regulated gene expression in the invading organism (Hogan et al.,
2004; Manefield et al., 2001; Persson et al., 2005; Rasmussen et al., 2005b). Acyl-homo serine
lactone analogs and other quorum sensing inhibitors (QSI) have been investigated to determine their
ability to prevent expression of quorum sensing controlled genes. QSIs may also reduce microbial
virulence by interrupting quorum communication thus preventing microbes to attack the host as a
unified army, by prevent the expression of pathogenic and virulence gene expression, and by
reducing or preventing the development of biofilm formation. Several compounds have been
identified that have the ability to interfere with QS-mediated gene expression (Manefield et al.,
2001) through competitive inhibition, thus reducing biofilm thickness (Hentzer et al., 2002).

QSI compounds produced by Fungi
Rasmussen et al. (2005a) studied 100 extracts from 50 Penicillium species and found that
33 produced QSI compounds. From these 100 extracts, penicillic acid and patulin (Figure 9–A, B)
proved to be inhibitory against P. aeruginosa QS-controlled gene expression. Further tests showed
that 3-day-old biofilms which were grown on patulin-treated media were more susceptible to
tobramycin treatment compared to untreated media, as indicated by a higher degree of cell death.
Secondly, studies in a mouse model of chronic pulmonary infections showed that after 3 days of
treatment with patulin, there was a 20-fold decrease of bacterial count compared to untreated mice.
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These investigators showed that when QS communication is blocked, the host immune system is
better able to combat infection. One way that host-derived polymorphonuclear leukocytes
neutrophils (PMNs) can clear infection within a host is by production of hydrogen peroxide (H 2O2).
This activity is blocked by rhamnolipids, which are P. aeruginosa QS-expressed compounds.
Rasmussen‘s group (2005a) demonstrated that if the QS communication can be blocked by a
quorum sensing inhibitor, PMNs could function normally. The compound patulin interrupts
pseudomad QS-mediated gene expression; thus PMNs are able to combat biofilm infections by the
production of H2O2 during oxidative burst.

QSI Compounds Produced by an Alga
Halogenated furanones (Figure 9-C) are QSI molecules that are produced by the micro alga
Delisea pulchra. These compounds have been shown to prevent quorum sensing gene expression in
various organisms. For example, Hentzer et al. (2002) showed that synthesized furanone 56, a
halogenated furanone of Delisea pulchra is able to block Las I/R quorum sensing system of P.
aeruginosa and prevent expression of elastase and chitinase. Confocal microscopy demonstrated
that this furanone helped reduced biofilm thickness (after 7 days) from 61 + 6 m (untreated) to 23
+ 4 m (treated), and it lowered QS-mediated gene expression, as measured using fluorescent
markers. The appearance of bioluminescence in Vibrio fischeri and swarming motility in Serratia
liquefaciens are also affected (Manefield et al., 2001). The furanone (4-bromo-5(bromomethylene)-3-(1‘-hydroxybutyl)-2-(5H)-furanone) has been shown to inhibit antibiotic
production and many extracellular degradative enzymes (pectate lyases, cellulases and proteases) in
the plant pathogen Erwinia carotovora.
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QSI Compounds Produced by Plants
Plant extracts have also been examined for QSI activity (Adonizio et al., 2006; Rasmussen
et al., 2005b). Because of its extensive antifungal reputation in medicinal folklore, Allium sativum
L., commonly known as garlic, has been examined for this type of activity. Persson et al. (2005)
reported that toluene extracts of garlic contained several compounds with varying levels of quorum
sensing inhibition against Gram-negative transcriptional regulators Lux R or Las R. Specifically,
N-heptysulfanylacetyl–L-homoserine lactone, a synthetic derivative, showed QSI activity against
both Lux I/R and Las I/R QS mediated systems. Collectively, the evidence presented here suggests
that QSIs may be useful in the treatment and/or prevention of biofilm infections.

Figure 9: QSI molecules. A) Penicillic acid, B) Patulin and C) Halogenated Furanone
(Rasmussen et al., 2005b)

Combination Therapy
Since biofilm infections and antibiotic resistance are on the rise (Lewis, 2001), research
has begun to explore the effects of combination therapy to treat these types of infections
(Nascimento et al., 2000; Rasmussen et al., 2005b). The term ―synergistic activity‖ is often used to
describe various herbal remedies in reference to the fact that their antimicrobial activity is
dependent on several compounds working in combination with one another within the whole plant
extract. A synergistic effect can be described where the combined resultant activity is greater that
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the ―sum of its parts,‖ compared to an additive effect that is equal to the ―sum of its parts.‖ Many
studies have shown that a synergistic effect may be occurring between crude plant extracts and
antibiotic compounds against various resistant organisms (Nascimento et al., 2000; Rasmussen et
al., 2005b).
Betoni et al. (2006) looked at the effects of sub-inhibitory levels of eight plant extracts
(1/4 of MIC 90%) combined with 13 antibiotics against 32 strains of Staphylococcus aureus. Each
extract was able to produce a synergistic effect (synergy was defined as values p<0.05 of the
Wilcox nonparametric test) with at least two antibiotics. The highest level of synergy occurred
with antibiotics that worked by inhibiting protein synthesis (with five extracts/drug).
Tetracycline produced a synergistic activity with all eight of the extracts tested. Finally, the
weakest and the most potent extracts, from Cymbopogon citratus-lemongrass (MIC 90% --17.84
mg/mL) and Syzygium aromaticum-clove (MIC 90% --0.36 mg/mL) both showed synergistic
activity with 11 of the 13 antibiotics tested. This suggests that synergy maybe an important
aspect in antimicrobial treatment against resistant S. aureus.
Aburjai et al. (2001) surveyed nineteen methanolic extracts of Jordanian plants. Extracts
were combined with seven antibiotics to determine effectiveness against both an antibioticresistant strain and a non-resistant strain of P. aeruginosa. Individual extracts increased activity
of some antibiotics while decreasing the activity of others. For instance, the methanolic plant
extracts from Euphorbia macroclada antagonized penicillin G and nalidixic acid activity,
allowing over 100% percent bacterial growth. In contrast, tetracycline inhibition was augmented
and only 26.9 % bacterial growth was observed. The extract of Mentha piperita L. prevented
gentamicin and erythromycin activity allowing over 100% growth activity compared to the
control, but in converse it augmented tetracycline inhibition, allowing only 26.1 % overall

23
bacterial growth. Thea sinensis L. extract had the most significant effect increasing tetracycline
inhibitory activity thus only allowing 13.0 % percentage growth. Of the seven antibiotics tested,
tetracycline was the most easily augmented, with five of the nineteen plants that were tested
against the resistant Pseudomonas strain.
Nascimento et al. (2000) demonstrated that a number of crude plant extracts, including
thyme, showed an increased killing effect against Pseudomonas species when combined with
ineffective dosages of commercial antibiotics. For example, the plant extract of Thymus vulgaris
can inhibit Pseudomonas growth at 70 g/mL; but when combined with ineffective doses (50
g/mL) of tetracycline, the amount of thyme needed to produce growth inhibition was reduced to
10 g/mL.

Thymus vulgaris
Thymus vulgaris, (Figure 10) is a well-known plant that has been regarded as a potent
medicinal herb for thousands of years. Thyme belongs to the family Lamiaceae, and is an
aromatic perennial, that grows to 20-30 cm in height. The stems are long-slender, woody and
quadrangular, and they grow from a basal center. The leaves are typically grayish-green in color,
smooth oblong-lanceolate in shape, and with little or no petioles which connect the leaves to the
woody stems. Set in pairs, the flowers grow at the top of these slightly twisting foot-stalks in a
whorl-like pattern. The petals grow in together in a form that creates a closed-corolla tube, and
they are typically pinkish-white in color with green sepals at the base of the corolla (Grieves,
1995; WHO, 1999)
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Figure 10: Thymus vulgaris.
(Grieve, 1995)

The word ―thyme‖ originated from the Greek word thymus, which means brave or
courageous. During ancient times it was used a fumigant, as it's aroma was meant to inspire
courage and bravery, and to invigorate and energize those who smelled it. During the middle
ages, people believed that the scent of thyme could keep away venomous creatures (Grieve,
1995). The flower and leaves were also used to treat a number of ailments. More recently,
thyme is a well-known and potent antiseptic, and useful for oral hygiene (WHO, 1999). The
plant has often been dried and made into an infusion, sweetened with honey and used to treat
sore throats. Syrup made out of the fresh herb was used to treat whooping coughs; it has also
been dried and added to tobacco "to promote good digestion" (Grieve, 1995). Other folkmedicinal uses include the treatment of coughs which stem from bronchitis, laryngitis, pertussis,
or tonsillitis (WHO, 1999). Present day uses include cooking, cosmetics, food preservation, and
antiseptic (Torras et al., 2007).
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Many of thyme's medicinal activities can be attributed to its essential oil. Essential oils
of plants are typically extracted from the plant leaves and flowers through steam distillation.
Constituents of essential oils include terpenes, monoterpenes, sequesterpines and phenols (Torras
et al., 2007). The major constituents of the essential oil thyme include: phenols, thymol and
carvacrol, which make up about 20-25% of the essential oils. The other constituents include
linaalool, p-cymol, cymeme, thymeme, pinene, apigenin, leteolin and geraniol (Grieves, 1995;
Torras et al., 2007; WHO, 1999). Fabio et al. (2007) found potent antibacterial activity of the
essential oil against seven various bacteria at a minimum concentration of 0.0002 mL/mL. Four
major constituents were chosen for further assessment due to strong scientific evidence of their
effectiveness against resistant bacteria and biofilm formations.

Four Main Constituents of Thyme
Baicalein (Figure 11) is a flavone compound that can be isolated from the methanolic
extract of Thymus vulgaris leaves; it has been shown to produce synergistic activities with
tetracycline and various β-lactam antibiotics against methicillin-resistant Staphylococcus aureus
(MRSA). It appears that the mode of action for this synergistic antibiotic effect varies,
dependent upon the resistant features of the organism, such as whether or not the MRSA
possesses the tetracycline-resistant efflux pump tet(K) (Fujita, 2005).
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Figure 11: Baicalein.

Rosmarinic acid (Figure 12) is a caffeic acid ester that is excreted naturally by roots of
the plant sweet basil when challenged by Pseudomonas aeruginosa (Walker et al., 2004). It is
also produced by several other aromatic herbs including Thymus vulgaris (Wang et al., 2004).
Rosmarinic acid has been shown to inhibit planktonic growth of some Pseudomonas spp., and
interferes with quorum sensing activities and biofilm development (Walker et al., 2004).
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Figure 12: Rosmarinic acid.

Thymol (2-isopropyl-5-methylphenol) (Figure 13.A) and Carvacrol (2 methyl-5-(1methylethylphenol) (Figure 13.B) are phenolic compounds both isolated from thyme and are
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known for their antimicrobial activity against many organisms, including MRSA. These
compounds have also been shown to interfere with staphylococcal biofilm growth (Nostro et al.,
2007).
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Figure 13: A) Thymol and B) Carvacrol.

Purpose
The purpose of this dissertation was to perform preliminary investigations on two
alternative treatment avenues against Pseudomonas aeruginosa infections: quorum sensing
inhibition and combination therapy.

First, fifty folk medicinal plant extracts were screened for

anti- quorum sensing properties. Next, specific attention was placed on the thyme extract, a folkmedicinal plant shown to possess anti-quorum sensing properties (Vattam et al., 2007) but also
first shown by Nascimento et al., 2000 to have synergism when combined with tetracycline
against resistant Pseudomonas aeruginosa. Furthermore, this study pursued the isolation and
identification of the active component in thyme involved in the thyme-tetracycline effect, and the
elucidation of its mode of action.
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Rationale
There are many clues indicating that ethanolic thyme extract may act as a quorum sensing
inhibitor, thus augmenting tetracycline activity. First, the thyme extract has been shown to
augment activity of various antibiotics, such as ampicillin, tetracycline and chloramphenicol
(Nascimento et al., 2000). Interestingly, these three antibiotics work through different modes of
action (Mims et al., 1998). This indicates a more general mode of action for the plant extract.
Aburjai et al. (2001) demonstrated that while the activity of tetracycline (typically active against
Gram-negative organisms) is augmented by various plant extracts, activity is greatly reduced
with other antibiotics such as penicillin G (typically active against Gram-positive bacteria). This
suggests that the mechanism involved may be type-specific. Next, tetracycline resistance occurs
by either expression of efflux pumps and/or ribosome protection expressed via the tet R protein
(Rosen and Mobashery, 1998). It has been shown that quorum sensing can modulate many
virulence genes including efflux pump expression (Lewis, 2001). Thus, control of quorum
sensing activity by an inhibitor would present a logical explanation of these observations.
More evidence suggesting that the thyme extract may include a QSI comes to light upon
examination of various green tea studies. Yam et al. (1997) studied the activity of Camellia
sinensis, green tea, against various bacteria. They discovered that ‗cup of tea‘ concentrations
showed considerable activity against many pathogenic bacteria including 18 strains of
methicillin resistant Staphylococcus aureus (MRSA). Tiwari et al. (2005) demonstrated that
epicatechin gallate (ECGC), a compound found in Camellia sinensis, can produce an amplified
effect when combined with the commercial antibiotic chloramphenicol against various strains of
Salmonella typhimurium. In this study, supplementation with ECGC reduced the amount of
antibiotic needed to cause growth inhibition. Tiwari suggested that this phenomenon occurred
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because of ―dual binding sites‖ which were triggered by the plant extract on the bacterial cell
membrane of the pathogen. A different study demonstrated that a possible synergistic interaction
between ECGC and oxacillin might be occurring during treatment of various methicillin-resistant
Staphylococcus aureus (MRSA), that would, in effect, reverse the resistance of the strains
(Hamilton-Miller and Shah, 2000). In 2003, epigallocatechin gallate (ECGC) was shown to
interfere with quorum sensing activities in E. coli and Pseudomonas reporter organisms (Huber
et al., 2003). Mode of action experiments can be used to determine if this is indeed the case with
the thyme extract.

Specific Aims
1. Screen fifty folk-medicinal plant extracts for QSI activity.
2. Examine specifically the extract of Thymus vulgaris and the ―thyme-tetracycline‖
effect:
a) Isolate and identify the active compound in the thyme extract that augments
tetracycline activity against resistant Pseudomonas aeruginosa.
b) Determine the most efficient way to extract the active compound from the
plant material.
c) Determine if quorum sensing inhibition is involved in the mode of action.
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MATERIALS AND METHODS

Chemicals and Reagents
The reagents used for this project—acetone, chloroform, dichloromethane, ethanol,
hexane, and methanol—were histological grade and purchased from Sigma-Aldrich, which is
located in St. Louis, Missouri. Media used for propagating bacterial cultures included LuriaBertani (LB), Mueller Hinton II (MH), Tryptic soy agar (TSA), and Nutrient broth (NB) and
came from Difco, located in Sparks, Maryland. Antibiotics—tetracycline free-base (purchased
from MP Biomedical, Inc. in Solon, Ohio) and tobramycin sulfate salt, gentamicin sulfate salt,
and kanamycin sulfate (all purchased from Sigma-Aldrich in St. Louis, Missouri). Thymol was
purchased from Fisher Scientific in Fair Lawn, New Jersey. Baicalein (98%), rosmarinic acid
(97%), and liquid carvacrol (98%) were purchased from Sigma-Aldrich in Steinheim, Germany.
The QSIS2 assay also required the following additives: N-butanoyl-L-homoserine lactone, C4
HSL (both from Cayman Chemical Company in Ann Arbor, Michigan), N-(3-oxododecanoyl)-Lhomoserine lactone, C12 HSL, and 2, 3, 5-triphenyltetrazolium chloride (from Sigma-Aldrich in
St. Louis, Missouri); concentrations were listed below where appropriate.

Bacterial Cultures
The QSIS2 reporter strain, Pseudomonas aeruginosa pLasB-SacB1, was graciously
provided by Dr. Michael Givskov of BioCentrum-DTU, Technical University of Denmark, and
the Chromobacterium violaceum ATCC 12472 used for the Chromobacterium QSI assay was
obtained from the American Type Culture Collection in Manassas, Virginia. P. aeruginosa

31
ATCC 10145, obtained from the Department of Biology at Georgia State University, was used
for the antibacterial studies.

Plant Samples
Plant material was either purchased from local area farmers‘ markets or hand-picked
from surrounding fields in Atlanta, Georgia. Thymus vulgaris samples were purchased from a
local farmers‘ market. Boneset, pokeweed, and yellow root were purchased from Golden Valley
Herbs-Hendersonville as a 40% ethanol extract. Taxonomic identification of all plant samples
was made using a minimum of two sources per specimen, including the United States
Department of Agriculture Natural Resources Conservation Services website
(www.plants.usda.gov) and a dichotomous key, such as Plant Families and How to Identify
Them (Jacques, 1949).

Extraction
Fresh thyme (10 g) was cut into ½-inch pieces and allowed to dry in an aerated incubator
at 55 C for 48 hrs. The plant material was extracted with 200 mL of ethanol in a covered flask
for 24-48 hours. The resultant liquid was filtered through a cotton ball filter into a round-bottom
flask and concentrated using a Buchi R-200 rotary evaporator, thus removing all the ethanol and
resulting in a viscous crude plant extract. All other plant extracts were prepared as described
above and tested at a concentration of 0.5 g/mL- solvent, respectively, except for ginger,
sassafras, rattlesnake master, and red root, which were tested at a concentration of 0.25 g/mL.
Subsequent extractions were made with slight modifications. For instance, thyme plant material

32
was also extracted with solvents including acetone, chloroform, ethyl acetate, hexane, methanol,
methylene chloride, and petroleum ether.
Comparative studies of the extraction of the thyme plant material were also made with
fresh, nonrecycled solvent and recycled solvent, or solvent collected after evaporation of a
previous sample. Fresh solvent extractions were made by soaking the bulk plant material in
previously unused solvent aliquots for each soak within the extraction process. For all recycled
solvent extractions, minimal amounts of fresh solvent were added only if necessary to
compensate for any solvent that may have been lost to evaporation during the extraction process.

Percentage Yield
The percentage yield of crude plant extracts was calculated as follows:
Weight of crude plant extract
x 100 = Percentage yield
Weight of starting bulk dried plant material

Disc Diffusion Assay (DDA)
Disc diffusion assay, as previously described by Mims et al. (1998) was used for all
antimicrobial studies. A pure culture of P. aeruginosa was prepared onto a nutrient agar plates
and incubated aerobically at 37˚C for 24 hours. Next, sterile saline tubes (pH 9.9) were
inoculated with the fresh overnight culture of organisms producing a turbidity equivalent to 0.5
McFarland Standard (BD diagnostic systems). Turbidity was matched through visual
comparison. Mueller Hinton II Agar plates, with 50 g/mL tetracycline, were swabbed
thoroughly using sterile cotton swabs saturated with the diluted bacterial suspensions. Next, 6-
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millimeter test discs (BD diagnostic systems) were prepared with 20 L of the diluted plant
extract (500 mg/mL) and allowed to air dry for a minimum of three hours. The impregnated
discs were placed aseptically in a radial fashion onto the inoculated plates. After 24 hours of
incubation at 37˚C, active plant samples will inhibit bacterial growth, thus resulting in a ―zone of
inhibition‖ around the disc. The diameter of these zones was measured in millimeters. Positive
control discs (10 L per disc) were prepared with tobramycin sulfate/water solution (1000 g/L).
The negative control discs were treated with straight ethanol.

Thin-Layer Chromatography (TLC)
Crude plant extracts and constituents were analyzed by thin-layer chromatography
(TLC). Samples were diluted in ethanol (100 mg/mL) and spotted on a 250 m 10 x 10 mm
silica gel 60 F254 plates (EMD Chemicals). Next, the plates were developed in 8:4:1 hexane,
dichloromethane, acetone system and allowed to air-dry in a fume hood. Plates were then
analyzed under an ultraviolet light for separation of compounds based on polarity.

Thin-Layer Chromatography Bioassay
Thin-Layer Chromatography Bioassay (TBA) adapted from Slusarenko et al. (1989) was
used for identification of the active antimicrobial components in the thyme extract. Plant extracts
and constituents were analyzed by thin-layer chromatography (TLC). Samples were diluted in
ethanol (100 mg/mL) and spotted on a 250 m 10 x 10 mm silica gel 60 F254 plate (EMD
Chemicals). Next, the plates were developed in 8:4:1 hexane, dichloromethane, acetone solvent
system and allowed to air-dry in a fume hood. An aliquot (25 mL) of nutrient broth with 1%
glycerol as added to 250 mL Erlenmeyer flasks. Next, one 10 L loopful of P. aeruginosa
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(grown aerobically overnight on nutrient agar at 37 C) was diluted into nutrient broth and grown
at 37 C in an orbital shaker (150-200 rpm) for 24 hours. Second aliquots (25 mL) of nutrient
broth were prepared with 1.5% (w/v) agar, 0.25 mL of 1% glycerol and 50 g/mL tetracycline
and referred to as TBA agar. They were later cooled to 45 C. The dye 2, 3, 5triphenyltetrazolium chloride was added to the agar, gently agitated, and set aside. The diluted
culture (1 mL) was added to the 25 mL TBA agar tubes and agitated. Finally, 50 mL of the agar
(2 tubes) were carefully poured into large Petri plates containing the thin-layer chromatography
plates. After 24 hours of incubation at 37 C, active compounds were identified by zones of
inhibition of microbial growth. The positive control was tobramycin, and it was spotted on the
TLC plate after the plate was developed; the negative control was any area of the TLC plate
without extract. The experiment was run in triplicate.

Activity-Driven Fractionation
The concentrated crude extracts were separated, based on polarity, into fractional
constituents, using an appropriate gradient solvent system on a solid-phase extraction (SPE)
product silica 5 g/20 mL column (Fisher Scientific, Fair Lawn, New Jersey) using a twelve-port
vacuum chromatography manifold.
First, the column was washed with pure hexane to prepare the silica. Next, the crude
extract was dissolved into methanol (~5 mL) added to the column. Then, the column was washed
with a minimal volume of hexane to allow the extract to saturate the top 5% of silica in the tube.
The column was then washed with hexane, totaling approximately 90 mL of hexane, until no
color was seen in the collected solvent. The first fraction was the combined hexane tubes. This
process was repeated with dichloromethane, acetone, and methanol. Tubes generated from the
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same solvent were recombined and roto-evaporated to remove eluting solvent from the fraction.
Fractions were re-diluted as needed for used for further testing.

QSIS2 Assay
The QSIS2 assay, adapted from Rasmussen et al. (2005b), with slight modifications as
described below, was used to screen plant extracts for C4 HSL and C12 HLS analogues. LB Agar
was made with the addition of 15.5 g sucrose (total volume 250 mL). The pH was adjusted to 5.0
with the addition of hydrochloric acid. Gentamicin (0.0247 g), kanamycin (0.0215 g), 1.1 mL of
each C4 HSL (0.00595 g/L of ethanol), and C12 HSL (0.00342 g/L of ethanol) plus 0.20 g of 2, 3,
5-triphenyltetrazolium chloride dye was added into 25 mL of phosphate-buffered saline (PBS).
The augmented PBS (25 mL) plus 2.5 mL of overnight QSIS2 reporter strain, grown in ABT
media (Rasmussen et al., 2005b), was added to the tempered LB agar and poured into Petri
plates. Next, the plates were allowed to solidify for 25 minutes. Wells (7 mm) were bored into
the solidified agar. Various dilutions of the plant extracts and major constituents were (50 µL per
well) were added to the wells. Agar plates were allowed to sit at room temperature for one hour
prior to incubation to allow the test solution ample time to diffuse into the agar. Plates were
incubated at 37ºC for 12-16 hours.
When QS-mediated gene expression is activated in the QSIS2 reporter strain, sucrose
mediated cell death occurs, but if QSI compounds are present in the test sample, QS-mediated
cell death is blocked and the reporter strain is able to grow. When cellular growth is achieved, a
zone of dark red growth is visible around the test well in only the areas where QSI molecule
concentration offsets QS signal concentration. The red color is caused by the metabolism of
triphenyltetrazolium chloride by the bacteria. This dye is used only to augment the bacterial
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zone of growth. Antimicrobial activity was detected by a transparent clearing around the well,
referred to as a ―zone of inhibition.‖ A second zone, referred to as a ―zone of growth,‖ consisted
of a bright red halo around the well, which indicated QSI activity. Experiments were run in
triplicate unless otherwise specified and zone diameters were measured in millimeters. All
diameter measurements were recorded in millimeters.

Chromobacterial QSI Assay
The Chromobacterial QSI assay protocol was adapted from Bosgelmez-Tinaz et al.
(2007) and was used for scanning samples for C4- C6 HSL analogues. Chromobacterium
violaceum ATCC 12472 was propagated in 5 mL of nutrient broth and incubated in a shaker
incubator for 24 hours at 30º C. LB Agar (250 mL) and LB broth with 0.3 % agar (250 mL) were
used to prepare an overlay assay. First, a Petri plate was filled halfway to capacity with LB Agar
and allowed to solidify for 30 minutes. Next, LB Agar (0.3%) was inoculated with 1 mL of
overnight culture. The tempered agar was poured over the LB Agar base and allowed to solidify
at room temperature. Wells (7 mm) were bored into the solidified agar. The test solution (50 µL
per well) was added into wells. Plates were left at room temperature for another hour to allow
test samples to diffuse into the agar. The plates were incubated for 16 hours at 30ºC. Violaceum
color production is under QS-mediated control. If the plant extract contains a QSI activity then
cellular growth will occur but pigment production will be prevented. Wells with zones of
inhibited color (opaque) were considered QSI active (zone of growth), and clear zones around
the well (transparent) were considered antimicrobial (zones of inhibition). Experiments were run
in triplicate and zone diameters were measured in millimeters.
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Garlic as the Positive Control for QSI Testing
A toluene garlic extract, adapted from Rasmussen et al. (2005b) was used as a positive
control for all QSI studies. Garlic (150 g) was shredded with a commercial blender and
extracted in 300 mL of toluene for 24 hours. After 24 hours, the sample was filtered through a
Whatman No. 1 filter. Next, the collected material was combined with 150 mL of sterile water
and mixed for 24 hours at room temperature. A separatory funnel was used to collect the toluene
extract (top layer), which was subsequently used as a QSI-positive control.

Glucose and pH Testing
Glucose concentrations of the crude plant extracts were measured using True Test gold
sensor strips with a True Test to-go blood/glucose meter (Home Diagnostics, Fort Lauderdale,
Florida). Crude extracts were first prepared by diluting the sample to a 0.2 g/mL into deionized
water. One drop of the extract was placed into a makeshift aluminum foil bowl. The meter strip
was then dipped into the solution. The solution travels up the strip by capillary action. Glucose
concentrations were read of the off the digital screen and recorded in dg/mL.
The pH of the samples was determined using colorpHast pH strips (EDM Chemicals).
The strips were submerged in the above 0.2 g/mL extract/water samples. Results were compared
to the pH scale on the package.
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RESULTS: SCREENING OF FIFTY FOLK-MEDICINAL EXTRACTS FOR QSI ACTIVITY

Folklore and Scientific Data
Table 1 describes the fifty bio-ethnically relevant plant extracts that were chosen to
screen for QSI activity. Bio-ethnical importance is based on either folkloric uses and/or previous
scientific data.
Table 1: Folklore and Published Test Results Pertaining to the Folk-Medicinal Plants
Tested.
Common name Scientific name Family name
Folklore
Published test
results
1 American
Asteraceae
Diuretic, tonic, Active against
Taraxacum
dandelion
urinary organs, C. albicans, S.
officinale
kidneys and
cerevisiae
liver disorder
(Cowan, 1999)
(Grieve, 1995)
2 American
Used as a
Previously
Aralia racemosa Asteraceae
spikenard
blood purifier, investigated for
and as a
its terpenoid
treatment for
components
other ailments
(Hanson and
including:
White, 1973)
asthma, cough,
diarrhea,
hemorrhoids,
leucorrhoea
and hay fever
(Hutchens,
1973)
3 Bamboo
Poaceae
Rich source of
Phyllostachys
hydrocyanic,
aurea
benzoic acid,
and tricin;
isolated from
bamboo is
considered
relatively safe
compound for
development as
a cancer chemopreventative
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Common name

Scientific name

Family name

4

Basil leaves

Ocimum
basilicum

Lamiaceae

5

Bay leaves

Laurus nobilis

Lauraceae

6

Bitter leaf

Vernonia
amygdalina

Asteraceae

7

Brown seaweed

Undaria
pinnatifida

Alariaceae

8

Boneset

Eupatorium
perfoliatum

Asteraceae

Folklore

Published test
results
agent (Jiao et
al., 2007)
Rosmarinic acid
produced by
sweet basil has
been shown to
be antibacterial
against
planktonic P.
aeruginosa cells
(Walker et al.,
2004)

Brazilian uses:
stomach aches,
headaches,
hepatic
complaints (Di
Stasi et al.,
2002)
Tonic,
antibacterial,
anti-tumor,
anti-parasitic
(Grieve, 1995)
Delisea pulchra,
a marine algae,
has been shown
to produce
several
halogenated
furanones that
are highly
effective QSI‘s
(Manefield et
al., 2001)
Used to treat
Showed to have
acute
a weak
bronchitis and
antimicrobial
nasopharyngeal activity against
catarrh
Gram-positives
(Habtermariam such as S.
and
aureus and B.
Macpherson,
megaterium
2000)
(Habtermariam
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Common name

Scientific name

Family name

Folklore

Chaparral

Larrea
tridentata

Zygophyllaceae

10 Chinese
dandelion

Taraxacum
mongolium

Asteraceae

11 Chinese
wolfberry

Lycium chinense Solanaceae
P. Mill

12 Chrysanthemum

Chrysanthemum
indicum

Used in a
Sonoran region
as a vermifuge;
external uses:
rheumatic
arthritis, and
tooth aches
internal uses:
inducing
abortion, and
menstruation
and expelling
afterbirth
(Grant et al.,
1998).
Chinese
folkloric uses
include:
inflammatory
diseases and
antiviral
activity (Shi et
al., 2008)
Chinese
traditional
uses: as a tonic,
and long life
and anti-aging
(Yeh et al.,
2008).
Oriental
folkloric uses
include fever,
pneumonia,
stomatitis, and
colitis; the
flowers were
used to treat
eye infections
(Sassi et al.,
2008)

9

Asteraceae

Published test
results
and
Macpherson,
2000)
Antiviral,
antifungal and
anti-tutor but it
also causes
hepatotoxicity
with prolonged
use (Grant et al.,
1998).

Antimicrobial
activity was
found by
Chrysanthemum
species against
P. aeruginosa
(Sassi et al.,
2008);
Chlorogenic
acid found in
some
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Common name

Scientific name

Family name

Folklore

13 Cinnamon

Cinnamomum
verum

Lauraceae

Astringent,
antiseptic,
diarrhea,
hemorrhaging
of the womb
(Grieve, 1995)

14 Clove

Syzygium
aromaticum

Myrtaceae

Antiseptic,
used to treat
tooth decay
(Grieve, 1995)

15 Cranberry

Vaccinium
macrocarpon

Ericaceae

Published test
results
Chrysanthemum
species may
play a role in
QSI activities
(Singh et al.,
2009)
Cinnamaldehyde
a main
component in
the essential oil
has been shown
to decrease E.
coli biofilm
formations (Niu
and Gilbert,
2004), and it
interferes with
C4HSL and
C6HSL QS
communication
(Niu et al.,
2006)
Active against
C. albicans
biofilm
formation,
(Agarwal et al.,
2008); Eugenol
a main
component in
cloves also
showed activity
against C.
albicans
biofilms (Hu et
al., 2007) but no
activity against
E. coli biofilm
development
(Niu and
Gilbert, 2004)
Antibacterial
(Cowan, 1999)
and has shown
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Common name

Scientific name

Family name

16 Dogwood

Cornus
sanguinea

Cornaceae

17 Elder berry

Sambucus nigra

Caprifoliaceae

18 Fennel

Foeniculum
vulgare Mill

Apiaceae

19 Fenugreek

Trigonella
foenumgraecum

Fabaceae

20 Garlic

Allium sativum

Liliaceae

Folklore

Published test
results
to inhibit
biofilm
formation on
uroepithelial
cells (Reid et al.,
2001)
Powdered bark Fruit from
was made into Cornus
toothpaste and officinalis when
the root bark
combined with
can be made
apple juice
into a scarlet
shown affect
dye
against E. coli
(Wu et al.,
O157H7;
2008)
antimicrobial
(Wu et al.,
2008)
Brazilian uses: Fruit contains
muscular pain, anthocyanins,
measles,
vitamins A and
varicella, fever, C, calcium, iron,
cough, bad
and vitamin B6
colds,
(Charlesbois,
hoarseness
2007)
(Di Stasi et al.,
2002)
Used as a
purgative, and
to treat
stomach
bloating
(Grieve, 1995)
Lactoferrin
extracted from
sprouts showed
activity against
Helicobacter
pylori (Randhir
et al., 2004)
Brazilian uses:
Hypertension,
colds, topically
used to treat
headaches

Effective
quorum-sensing
inhibitor
(Rasmussen et
al., 2005b)
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Common name

Scientific name

Family name

21 Ginger

Zingiber
officinale

Zingiberaceae

22 Grapefruit rind

Citrus paradisi

Rutaceae

23 Heath aster

Symphyotrichum Asteraceae
ericoides

24 Holly berries

Ilex opaca

Aquifoliaceae

25 Holly leaves

Ilex opaca

Aquifoliaceae

26 Hymenocrater

Hymenocrater
sessilifolius

Lamiaceae

Folklore
(Di Stasi et al.,
2002)
Brazilian uses:
stomach aches,
bad cold, and
cough
(Di Stasi et al.,
2002)

Published test
results

Showed no
growth
inhibition
against E. coli
ATCC 33456
(Niu and
Gilbert, 2004)
Rind and seeds Ascorbic acid
used for fungal showed QSI
infections, loss, activity against
treatment for
C. perfringens
cellulite and
(Novak and
weight loss
Fratamico,
(Annie‘s,
2004)
2005)
Native
American uses:
used in sweat
baths and to
revive
unconscious
patients
(USDA, 2004)
Berries are
mildly toxic
and will cause
vomiting
and/or diarrhea
(Grieve, 1995)
Leaves are
used to treat
fevers and
rheumatism
(Grieve, 1995)
Fever,
Active against
headache
C. albicans and
wounds, heart
Gram-negative
disease (Zaidi
bacteria (Zaidi
and Crow,
and Crow, 2005)
2005)
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Common name

Scientific name

Family name

Folklore

27 Hyssop

Hyssopus
officinalis

Lamiaceae

Tea used for
rheumatism,
paste used to
treat bruises
(Grieve, 1995)

28 Leather leaf
mahonia

Mahonia bealei

Berberidaceae

29 Lemon rind

Citrus Limon

Rutaceae

30 Lobelia

Lobelia inflata

Campanulaceae

31 Lo Han Kuo

Siraitia
grosvenori

Cucurbitaceae

32 Mint

Mentha piperita

Lamiaceae

Lemons were
used in the 18th
century to
prevent scurvy
(Baron, 2009)
Bronchitis,
diaphoretic,
exportant, antiasmathic
(Grieve, 1995)

Published test
results
Essential oil was
shown to be
bacteriostatic
against E. coli
O157H7
(Marino et al.,
2001)
Active against S.
aureus,
B. subtilis,
B. thuringiensis
(Li et al., 2008)

A piperidine
alkaloid has
been shown to
be active against
multidrugresistant tumor
cells
(Ma and Wink,
2008)
Emollient used Two novel
to treat dry
cucurbitane
coughs, dire
glycosides were
thirst and
isolated and
constipation
characterized
(Li eta l., 2006) from the unripe
fruit (Li et al.,
2006)
Brazilian uses: Species from the
topical
Lamiaceae
analgesic,
family is
worms,
antimicrobial
stomach pain,
against P.
bronchitis,
syringae B728a
cough
(Karamanoli and
(Di Stasi et al., Lindow, 2006)
2002)
but no QS
inhibition or
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Common name

Scientific name

Family name

Folklore

33 Mustard seed

Brassica nigra

Brassicaceae

34 Neem tree

Azadirachta
indica

Meliaceae

Brazilian uses:
antiinflammatory
used both
internally and
topically (Di
Stasi et al.,
2002)
Used to treat
measles (Lans,
2007)

35 Olive leaves

Olea europaea

Oleaceae

36 Oregano

Origanum
vulgare

Lamiaceae

37 Pokeweed

Phytolacca
americana

Phytolaccaceae

Astringent and
antiseptic, oil
is used as a
laxative and
hair tonic
(Grieve, 1995)
Brazilian uses:
bronchitis and
coughs
(Di Stasi et al.,
2002)
Extract was
used to treat
rheumatism
and

Published test
results
stimulation
against A.
tumefaciens
NT1 and C.
violaceum
CV0blu; active
against C.
albicans
biofilms
(Agarwal et al.,
2008)

Shown to be
affective as a
mouthwash
reducing
gingivitis and
cariogenic
bacteria
(Botelho et al.,
2008)
Inhibits bacterial
and fungal
growth
(Pereira et al.,
2007)
Essential oil
inhibits growth
against E. coli
O157:H7
(Marino et al.,
2001)
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Common name

Scientific name

Family name

Folklore

Published test
results

hemorrhoids
(Grieve, 1995)
38 Pomegranate

Punica
granatum

Lythraceae

39 Rattlesnake
master

Eryngium
aquaticum

Apiaceae

40 Red ginseng

Panax japonicus Araliaceae

41 Red root

Ceanothus
americanus

Rhamnaceae

42 Rosemary

Rosmarinus
officinalis

Lamiaceae

43 Sage

Salvia
officinalis

Lamiaceae

Brazilian uses:
stomach aches,
inflammation
(Di Stasi et al.,
2002)
Dropsy,
syphilis, liver
problems
resulting from
uric acid buildup, treatment
of infected
wounds
(Hutchens,
1973)
Improves
metabolism
and regulates
stomach and
intestine
functions
(Xiaoguang et
al., 1998)
Astringent,
mouthwash,
chronic
bronchitis,
whooping
cough,
dysentery,
injected as a
treatment for
gonorrhea
(Grieve, 1995)
Chinese uses:
arthritis and
snakebites
(Lans, 2007)
Restores
mental
function and

Effectively
reduced plaque
when used as a
mouthwash
(Palombo, 2009)

Shown to be
anticarcinogenic
(Xiaoguang et
al., 1998)

Ceanothic acid
was found to be
active against
oral pathogens
(Charlesbois,
2007)

Salvia apiana
was found to be
antimicrobially
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Common name

Scientific name

Family name

Folklore
improves
memory
(Errickson and
Sedia, 2005)

44 Sassafras

45 Silver berry
leaves

46 Sweet gum fruit

47 Thyme

48 Toxicanum

Syphilis, skin
diseases, and
chronic
rheumatism
(Grieve, 1995)
Elaeagnaceae
Combined with
Elaeagnus
sumac roots to
commutata
treat syphilis
(Palombo,
2009)
Hamamelidaceae Used to treat
Liquidambar
coughs, colds,
stryaciflua
diarrhea,
dysentery, and
ring worm
(Duke, 1994)
Whooping
Thymus vulgaris Lamiaceae
cough, sore
throat, colic
fever, cold
(Grieve, 1995)
Sassafras
albidum

Vincetoxicum
stocksii

Lauraceae

Asclepiadaceae

Injuries,
wounds, and
topical skin
cancers (Zaidi
and Crow,
2005)

Published test
results
active
(Errickson and
Sedia, 2005),
essential oil was
found to be
bacteriostatic
against 15
different
organisms
(Marino et al.,
2001)
Active against
helminthes
(Duke, 1994)

Active against
viruses, bacteria,
and fungi
(Cowan, 1999),
Thymol has
been shown to
be active against
C. albicans
biofilms (Braga
et al., 2008)
Highly active
against C.
albicans and
various bacteria
(Zaidi and
Crow, 2005)

48
Common name

Scientific name

Family name

49 Yellow root

Xanthorhiza
simplicissima

Ranunculaceae

50 Witch hazel

Hamamelis
virginiana L.

Folklore

Antiinflammatory,
astringent,
antimicrobial,
uterotonic,
immunostimulant
(Fetler and
Lloyd, 1898)
Hamamelidaceae Astringent,
tonic, sedative,
external
hemorrhaging,
painful
swelling and
tumors
(Grieve, 1995)

Published test
results

Crude plant
extract has been
shown to be
highly effective
against
periodontal
bacteria
(Palombo, 2009)

QSIS2 Assay Results of the Folk-Medicinal Extracts
Table 2 shows the QSIS2 assay results for both zones of inhibition, and zones of growth,
recorded in millimeters. Out of fifty crude extracts tested, thirty showed a transparent clearing, or
zone of inhibition, around the test well, suggesting antimicrobial activity. Thirty out of fifty
crude extracts also showed a QSI zone of growth. This can be recognized by a bright red halo
around the test well (Figures 14-17) at the location where the concentration of QSI molecule
offsets the concentration of the signal molecule. The largest QSI values were produced by the
extracts of clove (30 mm), cranberry (33 mm), chaparral (32 mm), ginger (30 mm), heath aster
(37 mm), pomegranate (36 mm), oregano (31 mm) sage (37 mm), and witch hazel (33 mm).
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Table 2: QSI Screening of Various Folk-Medicinal Plant Extracts using the QSIS2 Assay.
Zone of
Zone of
QSI
Samples
diffusion
inhibition
zone of growth
(mm)
(mm)
(mm)
1.
American dandelion
0
0
0
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.

American spikenard

0

10

18

Bamboo

0

0

27

Basil leaves

8

0

13, 31*

Bay leaves

8

10

23

Bitter leaf

0

0

29

Boneset

0

0

0

Brown seaweed

0

0

0

Chaparral

12

21

32

Chinese dandelion

8

42

0

Chinese wolfberry

0

0

0

Chrysanthemum

0

15

23

Cinnamon

0

10

20

Clove

0

19

30

Cranberry

0

24

33

Dogwood

0

0

0

Elder berry

0

13

26

Fennel

0

0

0

Fenugreek

0

11

18
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Zone of
diffusion
(mm)

Zone of
inhibition
(mm)

QSI
zone of growth
(mm)

Garlic (positive control)

0

10

14

Ginger

0

16

30

Grapefruit Rind

0

18

0

Heath aster

10

21

37

Holly berry

0

0

0

Holly leaves

8

0

0

Hymenocrater

0

12

0

Hyssop

0

15

26

Leather leaf mahonia

0

10

0

Lemon Rind

0

15

23

Lobelia

0

0

0

Lo han kuo

0

0

22

Mint

0

14

21

Mustard seed

0

0

0

Neem tree

0

0

0

Olive leaves

0

14

0

Oregano

12

16

31

Poke weed

0

0

0

Pomegranate

12

24

36

Rattlesnake master

0

15

23

Red ginseng

0

0

15

Samples
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
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Zone of
diffusion
(mm)

Zone of
inhibition
(mm)

QSI
zone of growth
(mm)

Red root

11

14

23

Rosemary

8

0

22

Sage

9

12

37

Sassafras

0

17

24

Silver berry leaves

8

0

0

Sweet gum fruit

0

15

17

Thyme

0

16

25

Toxicanum

0

10

0

Yellow root

0

0

0

Witch hazel

18

24

33

Samples
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.

Zone of diffusion = refers to the physical diffusion of the plant extract. Typically, this appears as
a color change in the agar that cannot be attributed to zone of inhibition or QSI activity.
*Sample has two QSI zones.

Images of QSIS2 Results of the Folk-Medicinal Crude Extracts

A

B

C

Figure 14: QSI results samples screened with the QSIS2 assay.
(A) (1) sassafras, (2) red root, (3) ginger, (4) rattlesnake master.
(B) (5) hyssop herb, (6) hymenocrator, (7) crysanthumum, (8) mint and 9) cinnamon
(C) (9) lemon rind, (10) grapefruit rind, and (11) olive leaf, (2+) garlic (positive control),
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(5) internal standard.

A

B

C

Figure 15: QSI results of crude extracts screened with the QSIS2 assay.
(A) (11) olive leaf, (12) toxicanum, (13) bamboo leaves, (14) clove, and (15) cranberry.
(B) (14) clove, (15) cranberry, (18) silverberry leaves, (19) holly leaves and (20) bay leaves.
(C) (21) rosemary, (23) pomegranate, (24) neem, and (25) mustard seed.

A

B

C

Figure 16: QSI results of crude extracts screened with the QSIS2 assay.
(A) (26) elder berry, (27) sweet gum fruit, (28) leather leaf mahonia, (29) sage, and (30)
dogwood bark.
(B) (31) chaparral, (33) Chinese wolfberry, (34) boneset, (35) heath aster, and (36) fenugreek
(C) (37) oregano, (38) fennel, and (40) lobelia.
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Figure 17: QSI results samples of crude extracts screened with the QSIS2 assay.
(42) witch hazel, (43) red ginseng, (44) Chinese dandelion, (45) lo han kuo, (47) thyme, (48)
cinnamon, (49) holly berry, (51) yellow root, (52) American dandelion, and (53) American
spikenard.

Glucose and pH levels of the Crude Extracts
Forty-two out of fifty samples were tested for pH as shown in Table 3. All samples had
an acidic pH with the exception of the yellow root extract (pH 7.0). Yellow root did not show
any QSI activity with the QSIS2 assay. Therefore, the pH did not seem to affect the QSIS2 assay
results for this sample.
Thirty-six extracts were tested for glucose concentration, as seen below in Table 3.
Preliminary sugar investigations consisting of analysis of various sugar dilutions (glucose,
fructose, dextrose and sucrose) were preformed to determine which concentrations yielded false
positive results with the QSIS2 assay. Glucose and dextrose did yield false positive zones of
growth halos with the QSIS2 assay. Interestingly, fructose and sucrose did not affect the assay
results (data not shown). This data suggested that samples with glucose reading of 254 mg/dL
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would produce false positive halo rings of 14 mm in diameter, with the QSIS2 assay. Thirteen of
the samples had a total glucose concentration of 254 mg/mL or below.

Table 3: Glucose Concentration and pH Readings of the Folk-Medicinal Extracts.
QSI assay
Glucose
Average glucose
equivalent
Sample Name
pH
Concentration
value
concentrations
(mg/dL)
(mg/dL)
(mg/dL)
American dandelion

4.5

169, 188, 173

176.7

441.7

Bamboo

5

479, 600, 599

599

1398.3

Basil Leaves

5.0

94, 89, 87

90

225

Bay leaves

4.5

275, 276, 276

275.5

689.2

Bitter leaf

4.0

Boneset

4.5

Chaparral

4.0

59, 65, 58

60.7

151.7

Chinese dandelion

4.0

348, 350, 414

370.7

926.7

Chinese wolfberry

4.5

Hi, Hi, Hi

>660

>1650

Chrysanthemum

4

Hi, Hi, Hi

> 660

> 1650

Clove

2.5

85, 103, 88

92

230

Lo, Lo, Lo

> 20

> 50

Lo, Lo, Lo

>20

>50

Cranberry
Dogwood

4.0

Elder berry

4.5

Fennel

5

211, 279, 223

237.6

594

Ginger

5

84, 76, 81

80.3

200.8

78, 70, 71

73

182.5

Grapefruit rind

55

Glucose
Concentration
(mg/dL)

Average glucose
value
(mg/dL)

QSI assay
equivalent
concentrations
(mg/dL)

519

1297.5

Sample Name

pH

Heath aster

4.5

Holly berry

4.0

Hi, Hi, Hi

> 660

> 1650

Holly leaves

3.5

Hi, Hi, Hi

> 660

> 1650

Hymenocrater

5

Hi, Hi, Hi

> 660

> 1650

Hyssop

4.5

218, 175, Hi

Leather leaf mahonia

5.0

482, 435, 485

467.3

1168

Lemon rind

3

259, 258, 293

270

675

Lobelia

5

Lo han kuo

3.0

139, 128, 148

138

345.8

Mint

4

30, 30, 30

30

75

Mustard seed

6.0

Neem tree

4.0

Olive leaf

3

78, 70, 71

421

1053

Oregano

4

70,50,58

59.3

148

Pomegranate

2.0

115, 118, 117

116.7

291.7

Rattlesnake master

3

21

52.5

Red ginseng

4.0

Hi, Hi, Hi

> 660

> 1650

Red root

4

203, 242, 245

230

575

Rosemary

4.5

46, 48, 45

139

347.5

Sage

4.0

125, 119, 120

121.3

357.9

505, 533,

__

21,

,
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Average glucose
value
(mg/dL)

QSI assay
equivalent
concentrations
(mg/dL)

Sample Name

pH

Glucose
Concentration
(mg/dL)

Sassafras

4

Lo, Lo, Lo

> 20

> 50

Silver berry leaves

6.0

38, 39, 38

39

97.5

Sweet gum fruit

3.0

Thyme

4.0

56, 76, 52

61.3

153.5

T toxicanum

5

366, 318, 339

341

852.5

Yellow root

7

Witch hazel

2.5

91, 51, 45

62.3

155.8

Crudes extracts were dissolved in water for both glucose and pH assessments at a concentration
of 200 mg/mL. Lo = indicates glucose concentration below 20 mg/dl; Hi= glucose concentration
content above 660 mg/dl.

Chromobacterial QSI Assay Results of the Folk-Medicinal Extracts
Table 4 lists the Chromobacterial QSI assay results of the extracts tested. Extracts were
tested in triplicate and recorded as trials A, B, and C. Nineteen out of the forty-five extracts
produced QSI zones of 10 mm or greater. QSI zones can be seen as opaque zones of growth
with inhibited pigment production in the corresponding photos (Figures 18-20). The largest zone
of activity (39 mm) was seen with the clove extract. Nine of the samples also produced a second
zone which appeared to have increased pigment production.
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Table 4: QSI Results of the Folk-Medicinal Plants Extracts using the Chromobacterial QSI
Assay.
Zone of QSI activity
Samples
(mm)
A

B

C

Average

American dandelion

8

8

8

8

American spikenard

14

10*

18*

14*

Bamboo

10

10

11

10

Basil leaves

14*

15*

12

14*

Bay leaves

21*

15*

18*

18*

Boneset

10

8

8

9

Brown seaweed

8

8

8

8

Chaparral

18

18*

25

20

Chinese dandelion

10

10

8

9

Chinese wolfberry

10

8

8

9

Chrysanthemum

10

9

10

10

Clove

40

43

32

39

Cranberry

19*

15*

12*

15*

Dogwood bark

8

8

8

8

Elder berry

12*

8

10

10

Fennel

12*

28*

25*

22*

Fenugreek

8

10

9

9

Garlic (positive control)

18

20

20

19

Ginger

11

10

10

10
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Zone of QSI activity
(mm)

Samples
A

B

C

Average

Grapefruit rind

9

9

10

9

Heath aster

12

16

10*

13

Holly berry

12

8

8

9

Holly leaves

8

8

8

8

Hymenocrater

9

9

10

9

Hyssop

12

12

11

12

Leather leaf mahonia

8, 30*

8, 30*

8, 30*

8, 30*

Lemon rind

9

9

10

9

Lo han kuo

10

8

9

9

Mint

10

9

10

10

Mustard seed

10

8

8

9

Neem tree

10

8

12

10

Olive leaves

8

8

8

8

Oregano

20

20

25

22

Pomegranate

23*

25*

27*

25*

Red ginseng

12

8

8

9

Red root

12

11

12

12

Rosemary

14*

12*

10

12*

Sage

19

20

21

20

Sassafras

20

22

20

21
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Zone of QSI activity
(mm)

Samples
A

B

C

Average

Silverberry leaves

8

8

8

8

Sweet gum fruit

8

8, 20*

8

8, 20*

Thyme

12

15

11

13

Toxicanum

10 *

10

12

11

Yellow root

12

8

11

10

Witch hazel

22

25

25

24

* Indicates a second darker purple zone was present around the well.

Images of Chromobacterial QSI Assay Results of the Folk-Medicinal Extracts

Figure 18: QSI results of crude samples screened with the Chromobacterial QSI assay.
(1) Sassafras, (2) red root, (3) ginger, (5) hyssop, (6) hymenocrater, (7) chrysanthemum, (8)
mint, (9) lemon rind, (10) grapefruit rind, (11) olive leaf, (12) toxicanum, (13) bamboo, (14)
clove, (15) cranberry, and (+) positive control toluene garlic extract.
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Figure 19: QSI results of the crude extracts screened with the Chromobacterial QSI assay.
(17) Brown sea weed, (18) silverberry leaves, (19) holly leaves, (20) bay leaves, (21) rosemary,
(23) pomegranate, (24) neem, (25) mustard seed, (26) elder berry, (27) sweet gum fruit, (28)
leather leaf mahonia, (29) sage, (30) dogwood bark, and (31) chaparral.

Figure 20: QSI results from crude extracts screened with the Chromobacterial QSI assay.
(33) Chinese wolfberry, (34) boneset, (35) heath aster, (36) fenugreek, (37) oregano, (38) fennel,
(42) witch hazel, (43) red ginseng, (44) Chinese dandelion, (45) lo han kuo, (47) thyme,
(49) holly berry, (51) yellow root, (52) American dandelion, and (53) American spikenard.
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RESULTS: THE THYME-TETRACYCLINE EFFECT

Disc Diffusion Assay of Ethanol Extract of the Thyme Leaves
Table 5 shows the DDA results of the ethanolic extract of the thyme leaves demonstrating
the lowest concentration of the extract which would exhibit inhibition activity against P.
aeruginosa ATCC 10145. The lowest usable concentration of this extract was a dilution of 250
mg/mL (262), showing zone sizes of 8 mm and 7 mm with cultures grown on both the Mueller
Hinton II (MH) and Tryptic soy agar (TSA), respectively. Activity was only seen with the
addition of tetracycline in the agar at this concentration. At a higher concentration of 500 mg/mL
(Figure 21) zone of inhibition diameters were increased from 8 mm to 11 mm with the addition
of tetracycline. Overall observations included: (1) Tetracycline in either of the agars augments
activity of the extract. (2) Larger zones of inhibition were observed in those cultures grown on
MH as compared to those grown on TSA. (3) Concentrations of 500 mg/mL at 20 μL per disc
produced the most consistent results on the MH agar.

Figure 21: DDA of ethanol extract of Thymus vulgaris leaves at a 500 mg/mL concentration.
Plate on left is Mueller Hinton II without tetracycline; plate on right is Mueller Hinton II with
tetracycline.
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Table 5: DDA of Ethanol Extract of Thymus vulgaris Leaves.
MH with
TSA with
Concentration
MH
TSA
Sample description
tetracycline*
tetracycline*
(mg/mL)
(mm)
(mm)
(mm)
(mm)
261
500
8
11
0
7
262
250
0
8
0
7
263
125
0
0
0
0
264
62.5
0
0
0
0
Positive control
1 μg/mL
27
27
23
22
(Tobramycin)
Negative control
0
0
0
0
(Blank disc)
Inhibition values are an average of 4 replicates. Diameter of disc 6 mm, 20 μL of plant extract
per disc, and 10 μL of tobramycin per disc.
*50 μg/mL of tetracycline was used.

Identification of Active Compound(s) by Thin-Layer Chromatography Bioassay.
Figure 22 show the results of an overlay assay on a 2D thin-layer chromatography (TLC)
plate which was used to separate the ethanolic leaf extract into its individual components.
Activity appeared to be isolated to a single zone of inhibition located at the top third of the plate.
In Figure 22, the arrow indicates the probable location of the active component(s). This
compound is later referred to as compound #2. The zone of inhibition is seen regardless of the
addition of tetracycline to the agar.
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Figure 22: 2D-TBA of the thyme leaf extract.
(A) Without tetracycline in the agar.
(B) This agar contains 50 µg/mL of tetracycline; a clear zone of inhibition is seen around the
active component, which is located on the top third of the plate.

Extraction of the Thyme Plant
Comparison of thyme leaves extracted in various solvents.
Figure 23 show the TLC results of thyme leaves extracted with various solvents (acetone,
chloroform, ethanol, ethyl acetate, hexane, methanol, methylene chloride, and petroleum ether).
Table 6 shows the corresponding percentage yield. Based on TLC results, it appears that the
active component can be extracted in all the solvents tested, but the hexane extract contained the
least number of inactive compounds. Hexane was also an easier solvent to work with based on its
innate properties such as boiling point and hexane‘s ability to remove the least amount of
undesirable compounds. This extract was used in several subsequent experiments.
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Figure 23: TLC comparison of crude extracts of thyme leaves prepared with various
solvents. Thyme leaves extracted in (by row): (1) ethanol, (2) hexane, (3) petroleum ether, (4)
methylene chloride, (5) chloroform, (6) ethyl acetate, (7) acetone, (8) ethanol, (9) methanol, and
(10) ethanol and (11) stems extracted in ethanol.

Table 6: Percentage Yield of Crude Extracts Produced by Extraction of Thyme Leaves in
Various Solvents.
Starting material dry
Crude weight
Yield
Sample description
weight (g)
(g)
(%)
Hexane
8.0
0.25
3.13
Petroleum ether
8.0
0.20
2.50
Methylene chloride
8.0
0.60
7.50
Chloroform
8.0
0.95
11.88
Ethyl acetate*
8.0
0.90
11.25
Acetone
8.0
1.00
12.50
Ethanol*
8.0
0.90
11.25
Methanol
8.0
0.75
9.38
Most extracts were prepared in duplicate values and are an average of two aliquots.
* Extracts not made in duplicate.

Gradient extraction of thyme leaves using recycled and non-recycled hexane.
Figure 24 shows the TLC of eight consecutive hexane filtrates. TLC results were taken of
each hexane filtrate prior to combining with the previous days filtrate. Table 7 shows the
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corresponding percentage yields. Based on TLC results, it appeared that the active compound(s)
could be collected by three consecutive hexane filtrations 163 and 164. By the forth filtration, a
second group of compounds were being extracted, those possessing a more polar nature.
Graduated extraction of the thyme leaves in hexane showed that there are definite increases in
the polarity of compounds removed from the bulk material as subsequent filtrates were collected.
Thin-layer chromatography results (Figure 24) also revealed that by the forth extraction, the allsimilar nonpolar compounds have been removed. In addition, it was interesting that there was a
definite difference in the compounds when extracted with non-recycled solvent (left rows) verses
recycled solvent (right rows) (Figure 24).
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Figure 24: TLC results of graduated extraction of thyme leaves using recycled and nonrecycled hexane.
Rows left to right are samples 152-166, ethanol leaf extract, plus thymol and carvacrol standards.
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Table 7: Percent Yield from Gradient extraction of Thyme Leaves using Recycled and
Non-recycled (Fresh) Hexane.
Starting
Days
Crude weight
Yield
Sample
Description
material dry
soaked
(g)
(%)
weight (g)
24-hour
152
Fresh hexane filtrate 1
8.0
0.1
1.25
soak
161
Fresh hexane filtrate 2
9 days
8.0
0.2*
2.5*
163
Fresh hexane filtrate 3
4 days
8.0
0.5
6.25
165
Fresh hexane filtrate 4
2 days
8.0
0.1
1.25
160
Recycled hexane filtrate 1
24 hrs
8.0
0.1
1.25
162
Recycled hexane filtrate 2
9 days
8.0
0.2*
2.5*
164
Recycled hexane filtrate 3
4 days
8.0
0.05
0.625
166
Recycled hexane filtrate 4
2 days
8.0
0.05
0.625
*Approximate values

Hexane, methanol, ethanol extractions using non-recycled solvent each of three soaks.
Figure 25 depicts TLC results of Thymus vulgaris leaves were consecutively extracted a
total of three 24-hour soaks with non-recycled hexane, methanol, or ethanol. Figure 25 depicts
the thin-layer chromatography results of these fractions. Table 8 shows the DDA results of the
combined crude extracts for each solvent: ethanol aliquots (270 and 271), methanol (272 and
273), and hexane (274 and 275) using MH agar. Table 9 shows the percentage yield of all
extracts. Disc diffusion assay results revealed that both methanol aliquots (272 and 273) showed
an increase in inhibition activity. Zone values increased from 8 mm to 13 mm with the addition
of tetracycline in the MH agar.
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Figure 25: TLC of extracts samples 270-275 (thyme leaves) extracted in hexane, methanol,
and ethanol, prepared using non-recycled solvent with each of three soaks.

Table 8: Disc Diffusion Assay Results of the Crude Extracts made with Non-recycled
Solvent for each Extraction in Hexane, Methanol, and Ethanol of Thymus vulgaris Leaves.
Mueller Hinton II with
Mueller Hinton II
Sample
Description
tetracycline
(mm)
(mm)
270
Ethanol crude A
7
10
271
Ethanol crude B
7
272
Methanol crude A
8
13
273
Methanol crude B
7
13
274
Hexane crude A
0
0
275
Hexane crude B
0
0
Experiment run in duplicate, values are an average of two runs. Two aliquots of plant material (A
and B) were extracted and tested. Each extract was tested at a 333 mg/mL concentration.

Table 9: Percentage Yield of Crude Extracts made with Non-recycled Solvent.
Starting material
Crude weight
Sample
Description
dry weight
(g)
(g)
270
Ethanol crude A
10.0
0.6
271
Ethanol crude B
10.0
2.3
272
Methanol crude A
10.0
1.0
273
Methanol crude B
10.0
1.6
274
Hexane crude A
10.0
0.2
275
Hexane crude B
10.0
0.4
Two aliquots of plant material (A and B) were extracted and tested.

Yield
(%)
6.0
23.0
10.0
16.0
2.0
4.0
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Hexane, methanol, and ethanol resoaks using recycled solvent each of three soaks.
Figure 26-A shows TLC results of extractions of thyme leaf samples extracted several
times using recycled solvent for each of three 24-hour soak each time. Figure 26-B shows the
corresponding TBA. Tables 10 and 11 (respectively) show DDA and percentage yield results for
the samples tested. Disc diffusion assay results (Table 10) showed that increased inhibition
activity was seen with the addition of tetracycline to the agar in all samples that were tested,
while the methanol leaf extract (301) showed the greatest increase in activity with the addition of
tetracycline to the MH agar. Zone values of the methanol leaf extract showed increases in
activity from 9 mm to 21 mm.
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Figure 26: TLC of thyme leaf extracts (Samples 300-303, 272) extracted with hexane,
methanol, and ethanol resoaks using recycled solvents with each soak. (A) TLC (B) TBA
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Table 10: Disc Diffusion Assay of Hexane, Methanol, and Ethanol Resoaks using Recycled
Solvent (300-303).
Mueller Hinton II
Mueller Hinton II with
(mm)
tetracycline (mm)
300
Ethanol crude
8
17
301
Methanol crude
9
21
302
Hexane crude
0
10
303
Methanol stem crude
0
14
Positive control
Tobramycin (20 µl)
35
37
Negative control
Empty
60
0
Concentration of sample on disc (20 µl) was 333 mg/mL.
Experiment was run in duplicate; zone values are an average of two runs.
Sample

Description

Table 11: Percentage Yield of Samples 300-303.
Starting material
Sample
Description
dry weight (g)
300
Ethanol crude
10.0
301
Methanol crude
10.0
302
Hexane crude
10.0
303
Methanol stem crude
10.0

Crude weight
(g)
1.2
1.6
1.7
0.7

Yield
(%)
12.0
16.0
17.0
6.8

Comparison of extractions of three soaks verses one soak using non-recycled solvent each
time.
Figure 27 depicts the TLC results of the thyme leaves extracted in non-recycled solvents
comparing the three 24-hour soaks versus the one 24-hour soak of the bulk material. Table 12
shows the corresponding percentage yield. Disc diffusion assay results (shown in Table 13)
showed that inhibition activity was seen in the E3 (305) sample and the M1, M3 (306, 307)
samples for the MH without tetracycline in the agar. The results are quite different when
tetracycline is in the agar. Inhibition zones greatly increase. The greatest increase in zone
diameters can be seen with sample M1 (306) sample, producing zones of 18 mm. After the third
soak, the inhibitive quality of the crude was reduced to 15 mm. This suggested that the most
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active components are most readily removed using methanol during a single 24-hour extraction
of the thyme leaves. The third soak of E3 (305) showed a higher activity than the E1 (304)
single-soak sample. Zone diameters can be seen increasing from 12 mm to 15 mm. Minimal
zone differences can be seen between the H1 (308) and the H3 (309) samples. Interestingly,
with the methanol stem single soak (MS1) and the stem three soak (MS3). There is no activity in
the MH without tetracycline but there is considerable activity with the MH with tetracycline.
Also there is a considerable decrease in activity between the single soak and the three soak
samples. MS1 produced zones of 16 mm while MS3 produced zones of 11 mm.
For maximum extraction of the active component(s) based on DDA results, a single 24hour methanol soak of the leaves is sufficient to remove the active components from the plant.
Therefore, while the hexane solvent is easier to handle based on innate solvent properties, the
most potent crude is produced with methanol.
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Figure 27: TLC comparison of three soaks verses one soak. Rows (Samples 304-311) are
thyme samples extracted in non-recycled solvent (ethanol, methanol, hexane, methanol stem
extracts).
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Table 12: Percentage Yield of Crude Samples (304-311) Comparing Three Soaks Verses
One Soak.
Starting
Crude
Yield
Sample
Description
material dry
weight
(%)
weight (g)
(g)
304
Ethanol single soak (E1)
10.0
0.28
2.8
305
Ethanol three soaks (E3)
10.0
1.82
18.2
306
Methanol single soak (M1)
10.0
0.52
5.2
307
Methanol three soaks (M3)
10.0
1.16
11.6
308
Hexane single soak (H1)
10.0
0.14
1.4
309
Hexane three soaks (H3)
10.0
0.38
3.8
310
Methanol stem single soak (MS1)
10.0
0.21
2.1
311
Methanol stem three soaks (MS3)
10.0
0.34
3.4

Table 13: Disc Diffusion Assay of Crude Samples (304-311) Comparing Three Soaks
Verses One Soak.
Mueller Hinton
Mueller Hinton II
Sample
Description
II
with tetracycline
(mm)
(mm)
304
Ethanol single soak (E1)
0
12
305
Ethanol three soaks (E3)
8
15
306
Methanol single soak (M1)
9
18
307
Methanol three soaks (M3)
8
15
308
Hexane single soak (H1)
0
11
309
Hexane three soaks (H3)
0
12
310
Methanol stem single soak (MS1)
0
16
311
Methanol stem three soaks (MS3)
0
11
Positive
Tobramycin (20 µL per disc)
36
37
control
Negative
Empty
0
0
control
Zone values are from an average of two experiments.

Column Chromatography of the Methanol Crude Extract
Column chromatography of the methanol single-soak crude extract (sample 307)
produced four fractions. These fractions are the hexane (312), the methylene chloride (313), the
acetone (314) and the methanol (315) fractions. Table 14 shows the DDA results of the methanol
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crude of leaves and the four corresponding fractions. The greatest amount of activity was seen
with the methylene chloride fraction (313), which showed an increase in zone sizes from 12 mm
to 16 mm with the addition of tetracycline. The methanol fraction also showed an increase in
zone size but only with the addition of tetracycline in the agar. Figure 28-B is a sketch of TBA
results performed on the methylene chloride fraction (313), and a significant zone of inhibition
was observed in the middle of the fraction lane on the TLC plate (Figure 28). This zone encircled
the dark green, green, and yellow and green spots on the plate. TBA and DDA results both
indicated that the highest concentration of the active component can be isolated in the center of
the methylene chloride fraction of the methanol crude on the TLC plate.

A

B

Figure 28: TLC of the methanol crude (307) and the corresponding fractions.
(A) hexane (312), methylene chloride fraction (313), acetone fraction (314), methanol fraction
(315). (B) Sketch of TBA results for the Methylene chloride fraction (313).
The circled region in sketch B indicates the zone of inhibition seen on the TBA.

73

Table 14: DDA Results of the Methanol Crude Extract and its Four Corresponding
Fractions.
Mueller Hinton II
Mueller Hinton II
Sample
Description
with tetracycline
(mm)
(mm)
307
Methanol crude
14
18
312
Hexane fraction
0
0
Methylene chloride
313
12
16
fraction
314
Acetone fraction
11
12
315
Methanol fraction
0
10
Tobramycin
Positive control
33
35
(20 µl per disc)
Negative control
Blank disc
0
0
Fractions were re-diluted into their corresponding elution solvent at a concentration of 500
g/mL. Experiments ran in duplicate, values are an average of these experiments.

Examination of the Four Major Constituents of the Thyme Plant.
Examination of the four major constituents by thin-layer chromatography.
(Figure 29) of the four constituents revealed that rosmarinic acid and baicalein did not
show any migration distance. This suggests that baicalein and rosmarinic acid samples are
probably not the active component, since they did not travel up the TLC plate in the 8:4:1
hexane, methylene chloride, acetone solvent system. Thymol and carvacrol both traveled twothirds up the plate. This was the approximate distance traveled by the active compound #2.
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Figure 29: TLC of four major constituents.
This is the TLC plate of the ethanol and hexane crude extracts of thyme plus the four major
constituents. Rows: (1) ethanol crude of thyme leaves, (2) thymol, (3) rosmarinic acid,
(4) baicalein, (5) carvacrol, (6) internal control, and (7) hexane leaf extract.

Comparisons of the Four Fractions and the Four Major Constituents

Comparisons of the fractions and the four major constituents by TLC and TBA
Figure 30-A is a sketch of the TLC plate seen in the subsequent, TBA (Figure 30-B).
Zones of inhibition were seen around active samples. The three inhibition zones seen from left to
right were located on the hexane crude, the thymol standard, and on the bottom-right tobramycin.
The hexane crude was chosen for two reasons: (1) during a previous DDA (Table 11), this
sample showed an increase in inhibition activity but only with the addition of tetracycline in the
agar and (2) There are a minimum number of undesirable compounds in the sample. Figure 31 is
a close-up of the hexane sample and the thymol standard. Clearly, the brightest area of the
hexane inhibition zone was located in the center of the spot, which was in direct alignment with
the thymol standard. These results (Figure 31) suggest that thymol may be the active component,
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but that carvacrol was also in direct alignment with thymol on the TLC plate (Figure 29). This
suggested that the active component was either thymol or carvacrol.

A

B

Figure 30: TLC diagram and TBA of hexane crude, thymol, and control.
(A) This is a diagram of the thin-layer chromatography plate featured in the thin-layer
chromatography bioassay (TBA).
(B) Zones of inhibition can be seen around hexane crude extract (128), the thymol standard, and
the tetracycline-positive control.

Figure 31: A close-up of rows of the above TBA.
Rows: hexane crude and thymol standard. Notice the spot on the left is brightest on the second of
three spots this spot is in direct alignment with the spot on the right, the thymol standard.
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Disc diffusion assay of major constituents at various concentrations
Table 15 shows the results from a DDA of the thyme plant four major constituents.
Rosmarinic acid and baicalein showed no antimicrobial activity at the concentrations tested.
Much higher concentrations were also tested without any activity (data not shown). Activity was
seen with both thymol at concentrations of (4800 µg/mL) and carvacrol at concentrations of
(480, 48, and 24 µg/mL) in both tetracycline and non-tetracycline samples. During a second
DDA (Table 16), thymol and carvacrol standards were run at much higher concentrations. These
experiments revealed that while both compounds showed antimicrobial activity, thymol showed
an increase in antimicrobial activity with the addition of tetracycline to the agar. Zone size
increased on average by 6 mm in diameter. Figure 32 visually depicts the increased thyme
activity at 2 concentrations, 500 mg/mL and 250 mg/mL. Therefore, these results along with
previous TLC (Figure 29) and TBA (Figures 30 and 31) suggested that thymol is the active
component in thyme, involved in the thyme-tetracycline effect.
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Table 15: DDA of Major Constituents at Low Concentrations.
Sample description
Mueller Hinton II
Mueller Hinton II
(mm)
with tetracycline (mm)
Baicalein ( g/mL)
480
0
0
44
0
0
22
0
0
11
0
0
5.5
0
0
3.0
0
0
1.5
0
0
0.75
0
0
Thymol ( g/mL)
4800 (in dark)
10
4800
10
480
0
0
48
0
0
24
0
0
12
0
0
6
0
3.0
0
0
1.5
0
0.75
0
0
Carvacrol ( l/mL)
480
12
12
48
9
10
24
7
7
12
0
0
6
0
0
3
0
0
3.0
8
9
1.5
0
0.75
0
0
Rosmarinic acid
( g/mL)
3.0
0
0
1.5
0
0.75
0
0
Positive control
26
25
(Tobramycin)
Negative control
0
0
(Blank disc)
Experiment run in triplicate; zone vales are average values of three experiments.
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Table 16: Disc Diffusion Assay of Thymol and Carvacrol Constituents at Higher
Concentrations.
Mueller Hinton II with
Sample description/concentration
Mueller Hinton II
tetracycline
Carvacrol
(mg/mL)
1000
10*
10
500
10
10
15.6
8*
8
Thymol
(mg/mL)
500
11
15
250
9
14
125
8
8
31.25
8
9
8
12
Positive control
(Ethanol leaf extract [500 mg/mL])
0
0
Negative control
(Blank disc)
Experiment run in triplicate; zone vales are average values of three experiments
*Values are from an average of 2 experimental values instead of 3 replicates.

A

B
Figure 32: Disc Diffusion assay of thymol. Plate on the left is Mueller Hinton II agar
without tetracycline, and plate on the right is Mueller Hinton II with tetracycline in the agar.
Thymol tested at a concentration of (A) 500 mg/mL [4], (B) 250 mg/mL [5].
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RESULTS: QSI ACTIVITY OF THYME AND ITS MAJOR CONSTITUENTS

QSI Activity of the Thyme Crude Extracts with the QSIS2 Assay
The results for the four crude thyme extracts chosen to assess potential anti quorumsensing activity with the QSIS2 assay are summarized in Table 17. The measurements are QSI
zones of growth (red halos) and antimicrobial zones of inhibition (clear zones). Figure 33 is a
compilation of images of representative samples demonstrating the visible activity.
The three polar extracts (ethanol signal soak crude [301], methanol single-soak crude
[306], and methanol stem three-soak crude [311]), all showed considerable QSI activity. Bright
red halos (seen in Figure 33 can be seen in photos B, C, and D. The most potent level of activity
was seen with the methanol-stem three-soak crude extract, which produced a QSI zone of growth
of 39 mm. The nonpolar hexane single-soak crude extract (308) shown in photo A of Figure 33
showed no activity at the concentration tested (0.0733 g/mL).

Table 17: QSI Activity of Crude Extracts with the QSIS2 Assay.
Antimicrobial zones QSI zones of growth
Sample
Sample description
of inhibition (mm)
(mm)
number
(concentration)
A
B
C
A
B
C
Ethanol single-soak crude
301
22
17
+
27
30
+
(1.000 g/mL) 301
Methanol single-soak crude
306
14
20
14
35
+
+
(0.164 g/mL) 306
Hexane single-soak crude
308
0
0
0
0
0
0
(0.0733 g/mL) 308
Methanol-stem three-soak crude
311
14
+
+
39
+*
+
(0.157 g/mL) 311
Positive control (Garlic)
15
25
Negative control (Empty well)
0
0
* Indicates zones were present but very faint in color.
+ Indicates that a zone of growth was detected although a measurement was not recorded.
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A

C

B

D

Figure 33: QSI results of various thyme extracts with the QSIS2 assay.
(A) Ethanol single-soak crude (301). (B) Methanol single-soak crude (306). (C) Hexane singlesoak crude (308). (D) Methanol-stem three-soak crude (311).
* A dark red halo indicates QSI activity, and a clear zone indicates antimicrobial activity. Halos
can be seen around A, B, and D (samples 301, 306, and 311).
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QSI Activity of the Major Constituents Using the QSIS2 Assay
All four of the major constituents showed QSI activity with the QSIS2 reporter strain.

Baicalein -- Table 18 shows corresponding values of zones of inhibition and zones of growth.
Figure 34 (A-C) depicts the results of baicalein tested at three concentrations: (A) 1µL/ mL, (B)
0.5 µL/mL, and (C) 0.125 µL/mL.

Table 18: QSI Activity of Baicalein Using the QSIS2 Assay.
Antimicrobial zone of
Concentration (µg/mL)
QSI zone of growth (mm)
inhibition (mm)
4
0
20
1
0
17
0.5
0
18
0.125
0
14
Positive control (garlic)
15
25
Negative control (empty wells)
0
0
Baicalein was dissolved in methanol. This constituent was tested at various concentrations, one
plate per concentration. These dilutions were not tested in triplicate.

C
A
B
Figure 34: QSI activity of baicalein at various concentrations with the QSIS2 assay.
(A) 1 µg/mL. (B) 0.5 µg/mL. (C) 0.125 µg/mL.
Baicalein appears to produce QSI zones of growth at all three concentrations.
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Thymol -- Table 19 shows the corresponding zone of inhibition and growth at concentrations of
500 mg/mL -3.9 mg/mL, constituent to solvent. Thymol showed potent antimicrobial and
anti quorum sensing activity at all the concentrations tested. Photos A and B in Figure 35 depict
QSI results of thymol dissolved in methanol at concentrations 500 mg/mL and 7.8 mg/mL,
respectively.

Table 19: QSI Activity of Thymol at Various Concentrations Using the QSIS2 Assay.
Antimicrobial zone of
Concentrations (mg/mL)
QSI zone of growth (mm)
inhibition (mm)
500
45
+
250
46
+
125
42
+
62.5
31
+
31.3
21
+
15.6
17
26
7.8
15
22
3.9
11
12
Positive control (Garlic)
16
+
Negative control (Empty well)
0
0
+ Indicates that a zone of growth was detected although a measurement was not recorded. This
constituent was tested at various concentrations, one plate per concentration. These dilutions
were not tested in triplicate.

A

B

Figure 35: QSI activity of thymol at various concentrations with the QSIS2 assay.
(A) 500 mg/mL. (B) 7.8 mg/mL. Both of these concentrations showed potent zones of growth.
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Rosmarinic acid -- Table 20 depicts the zones of inhibition and zones of growth at various
concentrations (200-25 mg/mL). Faint QSI zones of growth were seen at the concentrations
(200-50 mg/mL) of the samples tested. However, no activity was observed below the 25 mg/mL
concentration. Photos A-C in Figure 36 depicts QSI results of rosmarinic acid seen with the
QSIS2 assay tested at various concentrations: (A) 200 mg/mL, (B) 100 mg/mL, and (C) 50
mg/mL.

Table 20: QSI Activity of Rosmarinic Acid at Various Concentrations using the QSIS2
Assay.
Concentrations
(mg/mL)

Antimicrobial zones of
Inhibition (mm)

QSI zones of
growth (mm)

200
20
*+
100
18
*+
50
16
* 25
25
0
0
Positive control (Garlic)
15
25
Negative control (Empty well)
0
0
Zone measurements are an average of three replicate experiments.
* Indicates zones were very faint in color.
+ Indicates that a zone of growth was detected although a measurement was not recorded.

A

B

C

Figure 36: QSI of Rosmarinic acid at various concentrations with the QSIS2 assay.
(A) 200 mg/mL. (B) 100 mg/mL. (C) 50 mg/mL.
Faint zones of growth can be seen at all three concentrations.
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Carvacrol -- Table 21 presents a more extensive analysis of liquid carvacrol samples tested at
varying concentrations (1000-7.8 µL/mL). Both antimicrobial activity and anti-quorum sensing
activity was seen at all concentrations, with definitive measurements recorded at 62.5-15.6
µL/mL. Photos A-C of Figure 37 depicts QSI activity of carvacrol at various concentrations: (A)
62.5 µL/mL, (B) 31.3 µL/mL, and (C) 15.6 µL/mL, respectively. Notice the red halo around the
31.3 µL/mL carvacrol well.

Table 21: QSI Activity of Carvacrol at Various Concentrations with the QSIS2 Assay.
Concentrations
Antimicrobial zones of
QSI zones of growth
(µL/mL)
inhibition (mm)
(mm)
1000
39
+
500
40
+
250
38
+
125
30
+
62.5
27
36
31.3
18
22
15.6
16
14
7.8
11
?
Positive control (Garlic)
16
+
Negative control (Empty well)
0
0
+ Indicates a zone of growth was detected although a measurement was not recorded. This
constituent was tested at various concentrations, one plate per concentration.
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A

B

C
Figure 37: QSI activity of carvacrol at various concentrations with the QSIS2 assay.
(A) 62.5 µL/mL. (B) 31.3 µL/mL. (C) 15.6 µL/mL.

Chromobacterial QSI Assay
Figure 38 (photos A and B) depicts the QSI assay results for samples of the thyme
extract, baicalein, and garlic. Figure 39 (photos A and B) depicts Chromobacterial QSI assay
results for rosmarinic acid, carvacrol, and thymol. Table 22 shows the corresponding
antimicrobial and anti-quorum zone values. QSI zones can be seen around the thyme extract (21
mm) and the baicalein sample (18 mm). In addition, the second darker purple zone seen around
the baicalein well (Figure 38-B) may suggest an increase in violacein production, thus suggesting
an increase in QS activity. However, further assessment is needed.
QSI activity for three volumes (10 µL, 25 µL, and 50 µL) of the toluene garlic extract
were demonstrated zone diameters 10 mm and 13 mm respectively only for volumes of 25 µL
and 50 µL. This could be due to the softness of 0.3% LB agar, which can cause irregular zone
sizes. Therefore, only samples with zones of greater than 10 mm were considered active. Thus,
50 µL was determined to be the optimum volume for the garlic tested.
Rosmarinic acid (50 mg/mL) showed a QSI zone diameter of 10 mm, while thymol (7.8
mg/mL) and carvacrol (31.3 mg/mL) both showed significant antimicrobial and QSI activity.
Figure 39-B clearly depicts the difference between the antimicrobial activity (clear zone) and
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QSI activity (opaque zone). Antimicrobial zone diameters measured 15 mm for thymol and 26
mm for carvacrol. Thymol QSI zone diameters measured 22 mm, while carvacrol had zones of
34 mm.

Table 22: Chromobacterium QSI Assay of the Thyme Extract and its Main Constituents.
Antimicrobial
QSI
Sample descriptions
Zone of inhibition
Zone of inhibited color
(concentrations)
(mm)
(mm)
Thyme methanol leaf extract
1
?
21
500 mg/mL (50 µL per well)
Baicalein, 4µL/mL
2
?
18
(50 µL per well)
Toluene garlic extract
3
0
0
(10 µL per well)
Toluene garlic extract
4
0
10
(25 µL per well)
Toluene garlic extract
5
8
13
(50 µL per well)
Rosmarinic acid, 50 mg/mL
6
8
10
(50 µL per well)
Thymol, 7.8 mg/mL
7
15
22
(50 µL per well)
Carvacrol, 31.3 µl/mL
8
26
34
(50 µL per well)
9
Internal standard
0
12
10 Negative control (empty well)
0
0
Zone measurements are an average of three replicate experiments. The toluene garlic extract was
considered to be the positive control for this experiment.
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A

B

Figures 38: Chromobacterial QSI assay results of the thyme extract and its various
constituents. (A) The top side of the plate: (1) Thyme methanol leaf extract (500 mg/mL);
(2) baicilein (4 µg/mL); (3) toluene garlic extract (50 µL per well); (4) toluene garlic extract
(25 µL per well); and (5) toluene garlic extract (10aBBAB
µL per well). (B) The bottom side of the
B
plate. (From top to bottom, left to right, the samples B
are 1, 2, 3, 4, and 5.

A

B

Figure 39: Chromobacterial QSI assay results of the thyme constituents. (A) The top
side of the plate: (6) Rosmarinic acid (50 mg/mL); (7) thymol (7.8 mg/mL); (8) carvacrol
(31.3 µl/mL); (9) internal standard; and (10) negative control (empty).
(B) The bottom side of the plate. In this view, the difference between the zones of
inhibition (antimicrobial) versus the zone of inhibited color (QSI) is clear. Samples,
appearing from left to right, correspond to 6, 7, 8, 9, and 10 as mentioned above. (Notice
the zones of inhibition as completely clear versus the zones of growth [QSI] as opaque
zone around samples 7 and 8, thymol and carvacrol, respectively.)
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DISCUSSION AND CONCLUSION

The purpose of this dissertation was to perform preliminary exploration of two potential
alternative modes of treatment against Pseudomonas aeruginosa infections: quorum sensing
inhibition of folk-medicinal plant extracts and a specific example of combination drug therapy,
the thyme-tetracycline effect.
Because the prevalence of multidrug-resistant Pseudomonas is relatively high, many
researchers have begun exploring different options such as quorum sensing inhibition and
combination therapy as single drug treatment options have become less and less effective. Since
QSIs do not kill the pathogen, the selection pressure for development of resistance strains is
greatly diminished. To date, many known QSI‘s such as patulin and penicillic acid, have been
shown to be too toxic for human use (Rasmussen and Givskov, 2006).

Screening of Fifty Folk-Medicinal Extracts for QSI Activity
QSIS2 Assay
The first part of this study focused on screening fifty folk-medicinal plants for quorum
sensing inhibitory activity. Out of 50 plants tested, thirty plant families were represented. Thirty
samples showed QSI zones of growth as presented as a bright red halo. This assay detects C4 or
C12 HSL signaling inference. The QSIS2 assay works as such: The QSIS2 reporter stain harbors
a plasmid which contains a QS promoter gene attached to the levansucrase gene encoding cell
death. In the presence of sucrose and exogenous C4 and C12 HSL signal molecules, QS-mediated
cell death is triggered (Rasmussen et al., 2005b; Rasmussen and Givskov, 2006). When QSmediated gene expression is activated in the QSIS2 reporter strain, sucrose mediated cell death
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occurs, but if QSI compounds are present in the test sample, QS-mediated cell death is blocked
and the reporter strain is able to grow. Cellular growth is achieved and a zone of dark red growth
is visible around the test well in only the areas where QSI molecule concentration offsets QS
signal concentration. The red color is caused by the metabolism of triphenyltetrazolium chloride
by the bacteria, used only to augment the bacterial zone of growth.

If the concentration of the

QSI is too low or a compound in the sample has antibacterial effects then any cellular growth
and or erroneous background growth will be inhibited and a ―clear zone‖ will be seen around the
test well.
Thirty samples showed a transparent or clear zone inhibited growth suggesting
antimicrobial activity while twenty-four samples showed both types of activity. The plants
tested which showed a transparent or clear zone around the test well these values were recorded
as zones of inhibition. This lack of growth however, can be attributed to a number of factors: (1)
antimicrobial activity (transparent zone) provided by a component in the plant extract, (2) a lack
of a QSI compound in the extract (clear zone with the possibility of some background growth),
(3) concentration of a potential QSI compound is too low in a particular region of the agar (clear
zone with the possibility of some background growth). If a QSI is either not present or the
concentration is too low to offset signal molecules, than QS-mediated cell death will be induced.
All three scenarios produce cell death and a lack of growth around the test well.
Two variables that may lead to false positive results with the use of this QSIS2 reporter
strain are test samples with high sugar content or an alkaline pH. Rasmussen et al. (2005b)
stated that plant extracts with high sugar content can produce false positives with this QSIS2
reporter strain. Excess sugar content of a test sample may interfere with the sucrose mediated cell
death. Krisitis and Parsek (2006) suggested that alkaline solutions of pH 8.0 or greater can cause
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the acyl-homoserine lactone rings of the signal molecule to break open deeming them inactive.
Both of these variables were examined for the majority of the extracts.
Preliminary investigations of various sugar concentrations (dextrose, fructose, glucose,
and sucrose) and their effect on the assay were preformed to determine which concentrations
would yield false positive results with the QSIS2 assay. Interestingly, fructose and sucrose did
not affect the assay results. Glucose and dextrose, however, did yield false positive zones of
growth halos with the QSIS2 assay. This data showed that samples with glucose concentration of
254 mg/dL produce false positive halo rings of 14 mm in diameter with the QSIS2 assay (data
not shown). So, special care must be taken with when assessing samples with glucose
concentrations of 254 mg/dL or greater. High glucose concentrations in a plant extract do not
indicate lack of QSI activity just that the particular extract cannot be properly assessed with this
QSIS2 assay.
Another factor that may affect QSI results is pH of the samples. The AHL molecules are
very susceptible to pH changes. These molecules have been shown to have a half-life of several
hours at a pH of 7.0 and several minutes at a pH of 8.0 (Krisitis and Parsek, 2006). For this
reason, the pH of each extract was tested. All samples tested registered a pH of 6.0 or below
with the exception of yellow root which had a pH of 7.0. Disruption of a signal molecule would
prevent binding of the receptor thus allowing cellular growth and producing a false positive halo.
However, pH did not affect the assay results and no QSI activity was seen with this sample.

Chromobacterial QSI assay
Nineteen of the forty-one samples showed QSI activity with the Chromobacterial QSI
assay. QSI activity is observed as lack of violaceum pigment production in the assay. Samples
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showing this activity most likely contain compounds which act as C 4-C6 HSL analogues. Seven
samples produced zones of increased color pigmentation. One explanation for this is that the
extract might contain a second compound that augments QS-mediated pigment production.
There were a total of eleven crude extracts that had an acidic pH, low glucose content
(under 360 mg/dL), and showed anti-quorum sensing activity in both of the assays. These
extracts were: basil, chaparral, clove, cranberry, oregano, pomegranate, rosemary, sage,
sassafras, thyme and witch hazel. The results suggest that these extracts contain compounds
which interfere with C4 HSL bacterial communication. Interestingly, five of plants were from
the Lamiaceae family. Ginger and mint extracts also showed activity with the QSIS2 assay and
showed little to no activity with the Chromobacterial QSI assay. These results suggest analogous
interference with C12 HSL QS communication.
Rasmussen et al. (2005b) also screened many of these same plant extracts, and some
inconsistency has been determined in comparing the two studies. Their findings showed no QSI
activity for the extracts of clove, cranberry, ginseng (though this study used red ginseng) and
mint. However they used a different report strain. Their QSIS1 reporter strain screens
specifically for C6 HSL analogues.
Rasmussen et al. (2005b) reported a lack of activity with their C6 HSL analogue
screening assay for ginseng, clove and mint extracts. No activity was found for the
Chromobacterial QSI assay of red ginseng in this study, but we found activity with the QSIS2
assay. These results suggest that red ginseng may produce a C12 HSL analogue. Rasmussen et
al. (2005b) also reported that the clove extract did not have QSI activity; in contrast, the assays
carried out in this study showed considerable activity. One possible explanation is that the clove
produces C4 HSL analogues, compounds that may have not been identifiable with the assay used
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in Rasmussen‘s study.

The mint extract showed activity with the QSIS2 assay, which suggests

C12 HSL communication interference as well.
Vattem et al. (2007) also screened basil, ginger, oregano, rosemary and thyme extracts
with a similar Chromobacterial QSI assay type assay utilizing the Chromobacterium violaceum
CV026 strain. This strain requires the addition of exogenous signal molecules for activity. Their
findings were similar and consistent with those of this project.
Combination treatments such as antibiotic-antibiotic treatments have been discussed by
many researchers (Driscoll et al., 2007). Plant extract-antibiotic combination studies have been
explored by others including: Aburjai et al., 2001; Betoni et al., 2006; Nascimento et al., 2000.
Several researchers (Hamilton-Miller and Shah, 2002; Rasmussen et al., 2005b) have also shown
great promise using quorum sensing inhibitor-antibiotic combinations against biofilm and other
types of infections.

The Thyme-Tetracycline Effect
The second part of this study focused on the medicinal folklore plant Thymus vulgaris.
Several researchers have shown that thyme has antimicrobial (Cowen, 1999) and anti-quorum
sensing activities (Vattem et al., 2007). This study demonstrates that the thyme extract can
specifically interfere with Pseudomonas aeruginosa C4 HSL signaling. Previous researchers
(Nascimento et al., 2000) have also shown thyme has the ability to augment antimicrobial
activity against resistant Pseudomonas aeruginosa. The combination of thyme and tetracycline is
more effective at killing tetracycline resistant P. aeruginosa than the either of the individual
components. Thus, this study set out to determine the active compound in the thyme extract that
causes this effect, and to present a potential mode of action.
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While thymol, a major constituent in thyme, is also well known for its antimicrobial
activity, this study appears to be the first to identify thymol as the active component in the
thyme-tetracycline effect.

QSI Activity of Thyme
In order to elucidate a mode of action for thyme in the thyme-tetracycline effect, various
extracts of thyme and its four major constituents were assessed for QSI activity.
Thyme -- A recent report (Vatten et al., 2007) found that a water extract of thyme
showed QSI activity with the Chromobacterium violaceum CV026. This wild type strain requires
the addition of exogenous C6 HSL signal molecules. They found that the thyme-water extract
reduced QS-mediated violacein production by 60%. This study also found QSI activity with the
Chromobacterium plate assay, producing QSI zones of 13 mm. This activity was substantiated
by the QSIS2 assay. Four extracts of varying polarity ethanolic leaf crude, methanolic leaf
crude, methanolic stem crude, and the hexane leaf crude were analyzed. Out of the four extracts,
the polar extracts (methanol and ethanol leaf extracts and a methanol stem extracts) showed
activity with the QSIS2 assay. However, the hexane nonpolar leaf crude extract showed no
activity. Next, the four main constituents (baicalein, rosmarinic acid, thymol and carvacrol)
were also examined for QSI activity using both the QSIS2 assay and the chromobacterial QSI
assay.
Baicalein -- Zeng et al. (2008) reported that baicalein showed potential QSI activity
against Pseudomonas aeruginosa using a computer-docking program. They also showed that
baicalein can augment ampicillin activity against resistant Pseudomonas sp. Cheng et al. (2007)
found synergy between baicalein and gentamicin against Gram-positive vancomycin-resistant
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Enterococcus sp. The data presented herein validates their findings. Bacilien produced a strong
red halo, which suggests QSI activity at all concentrations tested (Figure 3.2). The
Chromobacterium plate assay also validated QSI activity. Baicalein showed QSI activity with
both of the assays, but it did not show any antimicrobial activity in the DDA assays, and also it
did not augment tetracycline activity.
Rosmarinic acid -- Walker et al. (2004) performed studies on the root stems of sweet
basil, which produces rosmarinic acid in response to pseudomonad infections. These studies
found that rosmarinic acid does effect cell growth and Rhl I/R gene expression, and can prevent
biofilm formation. The QSIS2 assay showed faint zones of QSI activity at various concentrations
(200-25 mg/mL). Chromobacterium studies also substantiate these results producing QSI activity
at a 50 mg/mL concentration. Rosmarinic acid did show QSI activity but it did not augment
tetracycline activity in the DDA assays.
Thymol and Carvacrol -- Studies have shown that thymol and carvacrol can effect
biofilm formation in Staphylococcus (Nostro et al., 2007) and C.albicans (Braga et al., 2007;
Braga et al., 2008). Prior to this study, thymol and carvacrol had not been tested specifically for
QSI activity against Pseudomonas aeruginosa. This study appears to be the first to identify that
thymol and carvacrol can act as potent quorum sensing inhibitory agents as demonstrated by both
QSI assays. This study showed specifically that QS-mediated gene expression can be effected
by both compounds. Thymol and carvacrol showed QSI activity even at minimal concentrations
of 3.9 µg/mL and 7.8 µl/mL, respectively. While both compounds showed potent QSI activity,
only thymol could augment tetracycline activity against Pseudomonas aeruginosa ATCC 10145.
These two QSI assays also indicate that the thyme extract and its four main constituents
all show potential QSI activity. QSIS2 assay suggests that these compounds probably interfere
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with either C4 HSL of C12 HSL QS-mediated communication. The Chromobacterium QSI assay,
which can be used to screen for C4-C6 HSL analogues, further substantiates these results by
showing that the extract, along with the four main constituents, can all interfere with the C4 HSL
signaling in C. violaceum. This assay also shows that these compounds can repress the
expression of violacein, a pigment under QS-mediated control. The significance of a compound
that is able to prevent the QS-mediated gene expression of violaceum indicates that these four
major constituents should also be able to prevent other QS-mediated genes from being expressed,
and that other QS-mediated genes may down regulated including QS-mediated efflux pump
expression. Conclusively, all of the data suggests that the thyme extract does have the ability to
interfere with Pseudomonas aeruginosa QS-mediated gene expression. This evidence supports
the idea that the thyme extract and its major constituents are all potent QSIs; hence it may be
possible that the thyme extract and specifically thymol can provide tetracycline efficiency
against resistant pseudomonads.

Potential Mode of Action for the Thyme-Tetracycline Effect
The collective evidence herein may be used to devise a possible mode of action that can
explain the action of the thyme-tetracycline effect. Thymol was shown to be the active
component in the thyme-tetracycline effect. A mode of action that may explain this effect may
be that thymol is working as a C4 HSL analogue. The Chromobacterial QSI assay shows two
things. First, thymol can act as a C4-C6 HSL analogue at appropriate concentrations. Second, it
shows that gene expression (pigmentation) can be repressed by this compound. The second
assay QSIS2 reinforces the idea that thymol can act as a C4 HSL analogue. In Pseudomonas
aeruginosa ATCC 10145, thymol probably acts as an analogue and a competitive inhibitor for
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the Rhl R transcription receptor which is under C4 HSL control. In Pseudomonas aeruginosa, if
Rhl-R QS-mediated gene expression is repressed then increased MexAB-OprM efflux pump
gene expression is also repressed.
Sugimura et al. (2008) showed that if MexAB-OprM is suppressed by about 70 %, the
cell becomes 2-4 times more susceptible to tetracycline antibiotic. MexAB-OprM expression is
under QS-mediated C4 HSL-Rhl R binding control. If C4 HSL binding is prevented by a
competitive inhibitor such as thymol, for example, tetracycline can not be expelled from the cell
and concentrations increase as the molecules accumulate within the cell. Thus, efflux of
tetracycline would be greatly reduced, allowing accumulation of tetracycline in the cell to levels
which cause protein synthesis disruption. This would occur as tetracycline binds to the A site of
the T-RNA binding site, eventually causing cell death (Poole, 2001).
The conclusion of this investigation yielded that thymol, a well known antimicrobial
active constituent of Thymus vulgaris, and other Lamiaceae plants, can work in a synergistic
fashion with ineffective doses of tetracycline to augment antimicrobial activity against
tetracycline-resistant Pseudomonas aeruginosa ATCC 10145. A proposed mode of action for
the thyme-tetracycline effect is that thymol acts as a QSI inhibitor of C4 HSL communication,
preventing MexAB-OprM efflux pump expression, thus allowing tetracycline to accumulate in
the cell and cause cellular damage.
Collectively, these experiments show that quorum sensing inhibitors and maybe an
important component in treating P. aeruginosa infections. The screening of the fifty plant
extracts yielded several new QSI leads many from plant sources that have already been shown
safe for human consumption. Further testing would allow researchers to explore and develop
some of these leads into potential new treatments against Pseudomonas aeruginosa infections.
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